216-RICR-20-10-4
A. Wherever used in these Rules and Regulations the terms listed below shall be construed as follows:
16. "Dental hygienist", means a person with a license to practice dental hygiene in this State under the provisions R.I. Gen. Laws § 5-31.1-1.
19. "Education record" means those records that are:
40. "Physician" means an individual licensed in the United States to practice allopathic or osteopathic medicine pursuant to the provisions of R.I. Gen. Laws Chapter 5-37.
55. "Speech/language pathologist" means a professional who identifies, assesses, diagnoses, prevents, and treats speech, voice, language, communication, and swallowing disorders.
59. "Visual impairments" include:
B. A comprehensive school health program as defined in § 4.3(A)(11) of this Part, consists of three (3) components:
3. A healthful school environment.
C. The administrative head of school(s) is responsible for the comprehensive school health program and is required to:
1. Develop a manual of procedures (protocols) governing health education, health services and a healthful school environment. This manual must be available at the Superintendent's office and at each school. Procedures must address the statutory and regulatory requirements of this Part and include provisions pertaining to, but not limited to, the following:
2. Provide an adequate number of personnel for a comprehensive school health program in accordance with the statutory requirements and the requirements of this Part. Required personnel include no less than a school physician, dentist, certified health educator and a school nurse.
E. Nothing in this Part is meant to preclude any student or the parents of any student from pursuing their rights to appropriate educational services and accommodations guaranteed by Federal and State laws.
D. Pursuant to R.I. Gen. Laws § 16-21-36, all schools are required to post the DCYF child abuse hotline telephone number available on DCYF's Child Protective Services website.
The school committee for each school district is required to establish a district-wide coordinated school health and wellness subcommittee in accordance with the requirements of R.I. Gen. Laws § 16-21-28.
D. Pursuant to the RIDE certification requirements in 200-RICR-20-20-, Regulations Governing the Certification of Educators in Rhode Island and the provisions of this Part, teachers providing health education shall consist of:
G. All students in K through twelve (12) attending schools, are required to receive instruction in health and physical education as prescribed and approved by RIDE, for periods which shall average at least twenty (20) minutes in each school day in accordance with the provisions of R.I. Gen. Laws §§ 16-22-4 and 16-1-5(14).
A. The health education curriculum must:
A. Pursuant to R.I. Gen. Laws § 16-22-4, the health education curriculum must be based on the Rhode Island Health Education Framework: Health Literacy for All Students standards and consistent with the mandated health instructional outcomes incorporated at §§ 4.2(A) and (B) of this Part, and must be evidence-based. These outcomes must pertain to no less than the following required content area topics appropriate to grade or developmental level:
15. Safety and Injury Prevention: the causes, effects, treatment, and prevention of behaviors that can result in unintentional or intentional injury; and:
b. Teen Dating Violence (grades seven (7) through twelve (12)): defining dating violence, recognizing dating violence warning signs and characteristics of healthy relationships, as stipulated in R.I. Gen. Laws § 16-22-24, and as defined in this Part.
A. The physical education curriculum must:
B. Population-based services must include no less than the following components:
3. Reporting and managing any school-based communicable, environmental, or occupational disease, as directed by a physician and in accordance with Part 30-05-1 of this Title, Reporting and Testing of Infectious, Environmental and Occupational Diseases.
A. Each school must provide adequate and appropriate personnel and/or equipment to provide individualized health services to all students enrolled in the school. At a minimum, the services must include those ordered by a physician, such as medication administration.
1. All personnel providing individualized health services to students must be licensed and/or certified in Rhode Island in accordance with all applicable State laws and Regulations.
B. All students assisted by medical technology and/or with other specialized health care needs, who are currently enrolled in grades K through twelve(12); entering Kindergarten; or currently attending or entering a public school-sponsored preschool, must have as part of their permanent school health record, an individualized health care plan (IHCP) and/or an emergency care plan (ECP/EHCP), as necessary and/or appropriate to ensure health, safety, and learning for the student while at school or at school-sponsored activities. The plan must include, but not be limited to the following:
The administrative head of school(s) with the advice and consent of the school committee of each community, school district or appropriate non-public school authority (e.g., superintendent, headmaster or principal) is required to arrange for the appointment of all school health personnel necessary to implement the health services requirements described in this Part, pursuant to the requirements of R.I. Gen. Laws Chapter 16-21.
A. Qualifications and general duties of the school physician include the following:
7. At least annually, must review and approve school health service plans, protocols, and programs (except those developed and provided by the school dentist[s]) including but not limited to:
e. Reporting and management of infectious diseases and outbreaks, in accordance with Part 30-05-1 of this Title, Reporting and Testing of Infectious, Environmental and Occupational Diseases and RIDOH recommendations related to infection control in the school environment.
A. Qualifications and general duties of the school nurse include the following:
3. Must provide individualized health services to all public-school students in the community.
B. Exemption from Certified School Nurse Requirement
2. Registered nurses may not provide the population-based health services and other requirements of the school health program as described in this Part.
A. Qualifications
1. The school dentist(s)/public health dental hygienist/dental hygienist for a community must be licensed to practice dentistry/dental hygiene, respectively, in Rhode Island in accordance with R.I. Gen. Laws Chapter 5-31.1, and have at least three (3) years of clinical experience as specified in R.I. Gen. Laws § 16-21-9.
B. General Duties
6. Referrals of students screened by the school dentist, public health hygienist and dental hygienist, must be made in accordance with the provisions of R.I. Gen. Laws § 16-21-9(c).
F. If there is no evidence that the required health examination has been performed, the school must make provisions for the health examination by the end of the school year in which it is required.
H. Each school system may require additional health examinations, to ensure the mental and physical health of each student to participate in classroom, athletic, or special activities sponsored or conducted by the school.
A. Written or electronic documentation of the health examination results is acceptable and must be in a standardized format with one (1) copy available from RIDOH or any format that captures the same required fields of information.
A. Pursuant to R.I. Gen. Laws § 23-24.6-8, evidence that students under six (6) years of age have been screened for lead poisoning is required in accordance with guidelines established under R.I. Gen. Laws § 23-24.6-7.
C. A school must screen vision using evidence-based, optotype-based screening, or evidence-based, instrument-based screening, depending on the age of the student in accordance with the National Center for Children’s Vision and Eye Health's Vision Screening Recommendations (https://nationalcenter.preventblindness.org/vision-screening-recommendations) incorporated by reference at § 4.2(L) of this Part.
G. When a trained, unlicensed individual, or individuals from an outside entity, conducts the initial screening, the school nurse must rescreen the student before making a referral.
I. Periodic reporting of vision screening results to RIDE and/or RIDOH may be required.
C. Screening tools recommended for preschool and kindergarten (and grade one (1) if students cannot identify letters in random sequence) are:
D. Screening tools recommended for students in grades one (1) (if students can identify letters in random sequence) and grades two (2) through five (5), seven (7), and nine (9) are:
E. Instrument-Based Screening may be used as an alternative to distance visual acuity screening for:
3. If conducting instrument-based screening, record pass or refer.
B. For those students required to wear prescription glasses, screening should occur with student wearing glasses.
A. Referral of students to qualified vision professionals, such as an ophthalmologist, optometrist, pediatric ophthalmologist, or pediatric optometrist, must occur in the following circumstances:
C. The school nurse will follow up with students referred for further evaluation by an eye care provider (pediatric ophthalmologist, pediatric optometrist, ophthalmologist, or optometrist) to ensure treatment plans are implemented at school, if necessary.
B. Preschool Assessment of Stereopsis with a Smile (PASS) II is the recommended tool for stereoacuity screening with all students. Manufacturer's instructions must be followed for use of any tools used for stereoacuity screening.
B. Books with pseudoisochromatic plates should be used. Options include:
C. Manufacturer's instructions must be followed for use of any tools used for color vision deficiency screening.
B. Trained volunteers or other school personnel who are directly supervised on-site by a school nurse may be utilized in the vision screening program.
A. A student who does not pass vision screening must be rescreened on a different day and as soon as possible but no longer than six (6) months before the parents/caregivers are notified of the results of the screening.
B. If the corrected visual acuity of the student is found to be in the range of 20/70 – 20/200 in the better eye after an eye examination, the school nurse in charge of the screening must, within thirty (30) days, report the result of the eye examination to the administrator of the Division of Services for the Blind and to the Special Education Supervisor, indicating that specialized services may be indicated.
E. Any student who provides documentation from a parent that a hearing screening test has been performed in accordance with § 4.14.1(A) of this Part is exempt from this screening requirement.
1. In the absence of this documentation from the parent, the school is required to make provisions for the screening.
All equipment utilized in the hearing screenings must be calibrated according to the American National Standards Institute Specifications for Audiometers incorporated at § 4.2(H) of this Part.
C. Any supporting personnel utilized by an audiologist/speech language pathologist in the hearing screening program must meet the requirements in Part 40-05-33 of this Title, Speech Pathologists and Audiologists.
D. A student's hearing screening results must be entered into the school health record by the school nurse, or the person performing the screening. At a minimum, the following components must be noted in the record:
A. Every elementary school student who has not been previously screened for speech/language impairments must be screened for speech and language impairments by a trained and qualified person as described in § 4.15.2 of this Part. Any student may be screened on an “as needed” basis.
B. Any student who has never been previously enrolled in a Rhode Island school who provides documentation from a parent that a speech screening has been performed by a certified and/or licensed speech language pathologist must be exempt from this screening requirement.
C. A speech/language screening must consist of an assessment of the following:
4. Receptive/expressive language skills.
B. Any support personnel (e.g., a speech/language pathology assistant) utilized by a speech/language pathologist must meet the training and supervision requirements outlined in Part 40-05-33 of this Title, Speech Pathologists and Audiologists.
B. In developing techniques for screening students ages eight (8) and above, informal items may be adapted from available tests. This informal screening would not provide standardized procedures but would yield an acceptable method of screening to determine the need for further testing.
B. The speech language pathologist or the school nurse must enter the results into the student's school health record.
1. The following components must be noted in the record:
F. The screening is not required of any student whose parents object on the grounds that the test conflicts with their religious beliefs.
A. Every student who has not been previously enrolled in a public or non-public school in this State must be given a dental screening by a licensed dentist, licensed dental hygienist, or a licensed public health dental hygienist with at least three (3) years of clinical experience.
1. Thereafter, every student must be given an annual dental screening by a licensed dentist, dental hygienist, or a licensed public health dental hygienist through the fifth (5th) grade and must be screened at least once between the sixth (6th) and tenth (10th) grades.
E. The initial dental screening preferably should be conducted by the student’s family dentist/dental hygienist within the six (6) months preceding the date of school entry, and the succeeding screenings should be conducted by him/her at any time during the school year (including vacations) for which the screening is required.
2. The RIDOH standardized form is available to all schools via the RIDOH website.
A. The school nurse is responsible for the complete, cumulative school health record for each student at the school in which the student is enrolled. The health record must include:
D. Appropriate steps must be taken for the protection of all student health records, including the provisions for the following:
E. The record must be maintained by the school for a minimum of five (5) years after the student turns eighteen (18) years of age or five (5) years after the student leaves the school district.
B. Any school personnel, including health care providers, who release confidential health care information from cumulative school health records in accordance with R.I. Gen. Laws § 5-37.3-4 ("Confidentiality of Health Care Information Act") and other applicable State and Federal laws and Rules and Regulations, must document each release in the cumulative school health records by indicating the following:
C. Violations Pertaining to Confidentiality: Any person suspected of violating the Health Care Information Act must be reported to the Attorney General's Office for prosecution and any subsequent penalties, in accordance with statutory provisions.
A. In accordance with the Rules and Regulations pertaining to Part 30-05-1 of this Title, Reporting and Testing of Infectious, Environmental and Occupational Diseases, the basic responsibility for reporting infectious, environmental and occupational diseases lies with:
D. No requirement in this Part shall be construed as prohibiting the issuance of a standing order by a school physician for the administration of an epinephrine auto-injector by a school nurse to a student who has not been previously medically identified for the prevention or treatment of anaphylaxis. This standing order must be reviewed in accordance with § 4.21(B) of this Part.
G. Students engaged in potentially hazardous tasks (including, but not limited to, activities during normal school hours in science laboratories, industrial arts, physical education, and family/consumer science classes) should be directly supervised by teachers or instructors who are trained in the administration of basic first aid, and who have posted and discussed safety rules with the students.
B. Requirements for automated external defibrillators (AEDs) in high schools and middle schools are pursuant to R.I. Gen Laws § 16.21-33.1(b).
Training must be provided for school personnel who might administer an epinephrine auto-injector in a case of anaphylaxis. Subjects to be covered must include, but not be limited to,: signs and symptoms of anaphylactic shock, proper epinephrine auto-injector administration, adverse reactions, accessing the "911" emergency medical system, and preparation for movement and transport of the student.
C. School health programs must develop and adopt a procedure for addressing incidents of anaphylaxis and the use of the epinephrine auto-injector on previously medically identified students. Such procedures must pertain to no less than the requirements described in this Part and must include the following:
G. In accordance with R. I. Gen Laws § 16-21-22(e), school districts may permit schools to maintain epinephrine auto-injectors for emergency first aid to students who experience allergic reactions.
School personnel who voluntarily assist persons suffering from anaphylaxis are immune from liability for ordinary negligence in accordance with R. I. Gen Laws §§ 9-1-27.1 and 16-21-22(d).
D. In addition to the requirements of R.I. Gen Laws § 16-21-32, the IHCP and EHCP must be part of the student’s permanent record, include both preventative measures to help avoid accidental exposure to allergens, and emergency measures in case of exposure. Additional measures shall include:
F. All school personnel who may be involved in the care of a student who has been diagnosed with a peanut/tree nut allergy must be informed of the IHCP and the EHCP, as appropriate.
B. Following a minor injury, the school nurse, or other appropriate school authority, must make a notation of the minor injury in a log book maintained by the school specifically for this purpose. At a minimum, the following items must be noted:
C. For each student, emergency information must be documented and updated on an annual basis. Such emergency information must include no less than the following:
D. Protocols or procedures shall be developed to require an individualized emergency care plan for a student at risk for anaphylaxis, asthmatic conditions and/or any other medical emergencies, as defined in § 4.3 of this Part.
F. School districts and schools are required to use training materials of the US Center for Disease Control and Prevention entitled "Heads Up: Concussion in High School Sports/Concussion in Youth Sports" or materials substantially equivalent.
A. All public and private elementary, middle, junior, and high schools must develop policies and procedures for the provision and maintenance of a supply of opioid antagonists (Naloxone) in the school setting to treat suspected opioid overdose in accordance with R.I. Gen. Laws. § 16-21-35.
B. Such policy or protocol must require no less than the following:
C. The student’s IHCP and EHCP must be part of their permanent school health record and be developed by the school nurse in collaboration with the student’s health care provider, the parents/guardians of the student, and the student (if appropriate).
A. As part of the ECP/EHCP, a parent or legal guardian may authorize school employees (or those employed on behalf of the school), for when there is no school nurse immediately available, to administer glucagon on such student in case of an emergency, while at school or school-sponsored activities.
3. Glucagon administration training may be provided by a licensed physician, physician assistant, advanced practiced registered nurse, or registered nurse, however in no case shall school nurses be required to provide the training.
A. Every school authority must develop protocols or procedures authorizing parents, parents’ designees, legal guardians, and school nurses in accordance with § 4.23.2 of this Part, to administer medical marijuana to a student while the student is on school campus. The protocols or procedures must include, at a minimum, the following:
3. Written instructions for medical marijuana administration that includes:
4. A requirement that all medical marijuana products utilized under § 4.23 of this Part shall only be obtained from a Rhode Island licensed compassion center. All medical marijuana products utilized must be labeled with the following information:
5. Documentation of each dose of medical marijuana administered to a student. Documentation must include:
E. A school is exempt from implementing the provisions of § 4.23 of this Part if the school can reasonably demonstrate that it would lose Federal funding as a result of the implementation of the provisions of § 4.23 of this Part.
A. Pursuant to R.I. Gen. Laws § 21-28.6-4(n), a school nurse may administer medical marijuana to a student. Administration of medical marijuana to students by school nurses must follow all requirements of § 4.23.1 of this Part. Additionally:
3. Nothing in this Part requires a school nurse to administer medical marijuana to a student, provided that the school nurse’s decision not to administer medical marijuana applies to all students authorized to use medical marijuana.
a. School’s whose school nurse refuses to administer medical marijuana shall make arrangements for the student to receive his or her medical marijuana during the school day.
A. Administration of medical marijuana to students by parents, parents’ designees, and legal guardians must follow all requirements of § 4.23.1 of this Part. Additionally:
1. Any medical marijuana taken onto the school campus by the parent, parents’ designee, or legal guardian must be either:
A. Each school district or authority must develop protocols or procedures related to medication administration in schools that include, at a minimum, the following provisions:
1. A school nurse must administer medication(s) to student(s) within the public school setting except as provided in §§ 4.21.4(F), 4.22.1, 4.24.3, 4.24.4, or 4.24.5 of this Part. The school nurse must be licensed in Rhode Island in accordance with the requirements of R.I. Gen. Laws Chapter 5-34. He or she must also be certified in accordance with the provisions of R.I. Gen. Laws § 16-21-8.
3. No lay person, other than a parent, may administer medication to a student in the school setting. Exceptions: §§ 4.21.4(F) and 4.22.1 of this Part (related to the administration of epinephrine and glucagon).
D. For prescription medications, all parent authorizations and licensed provider’s orders must be renewed no less than annually by the school nurse or other registered nurse.
Except as provided in § 4.2.5 of this Part, no controlled substance is permitted to be in the possession of or administered by anyone other than a school nurse, other registered nurse, licensed prescriber, or parent of the child for whom the medications have been prescribed. A student may deliver his/her own medication to school in accordance with protocols or procedures developed by the school but may not self-administer the controlled substance while on school property.
A. All school districts or school authorities must develop protocols or procedures to permit students to self-carry and/or self-administer prescription medication if the student, parent, school nurse or registered nurse, and licensed prescribing health care provider enter into a written agreement that specifies the conditions under which the prescription medication must be self-carried and/or self-administered. The school principal must be informed of the existence of said agreement.
B. The protocols or procedures related to student self-administration of medication must include provisions for the following:
C. A student is prohibited from sharing, transferring, or in any way diverting his/her own medication(s) to any other person.
A. Each school district must develop a procedure to allow students to carry and use prescription inhalers while in school or at a school sanctioned function or event, when prescribed by a licensed healthcare provider with prescriptive privileges. Students who carry inhalers must provide the school with medical documentation that the inhaler has been legitimately prescribed and that the child needs to self-carry due to a medical condition. No child shall be disciplined for failure to provide such documentation in advance.
1. No school teacher, school administrator, or school health personnel, or any other school personnel will be liable for civil damages which may result from acts or omissions in the use of prescription inhalers by children which may constitute ordinary negligence. This immunity does not apply to acts or omissions constituting gross negligence or willful or wanton conduct.
A. Each school district or non-public school authority must develop a procedure or protocol to allow students to self-carry and self-administer a day’s supply of medication for each day off-site, including a controlled substance, during an off-site school-sponsored activity.
A. Pursuant to R.I. Gen. Laws § 16-21-3, the State Building Codes Standards Committee, the State Fire Marshall, the State Health Department, and the Department of Labor and Training, Division of Occupational Safety shall determine whether the school buildings in the several cities and towns or on State property conform to appropriate State and Federal laws and Regulations within their respective jurisdiction.
B. Pursuant to R.I. Gen. Laws § 16-21-3.1, it shall be the responsibility of the school administrator, the non-public school official, in the case of State operated schools, the responsibility of the director of the State operated school, to ensure that schools are not opened until notification is received from the aforementioned agencies that the schools are in compliance with their respective codes.
A. All new construction or the alteration, extension, or modification of an existing building(s) is subject to all applicable Federal, State and local laws, codes, Regulations, and ordinances, including but not limited to the following regulatory provisions enforced by the specific agency:
2. The Uniform Federal Accessibility Standards (UFAS) incorporated at § 4.2(L) of this Part and State accessibility for persons with disability standards:
B. All architectural plans for school construction, renovations, or conversions must be submitted to the appropriate staff at RIDE, the Governor’s Commission on Disabilities, the State Building Commissioner and all other State or local agencies as appropriate prior to construction for review for compliance with all applicable Federal, State and local laws, codes, Regulations and ordinances.
A. All existing structures must comply with all applicable Federal, State and local laws, codes, Regulations, and ordinances including but not limited to the following regulatory requirements enforced by the specified agency:
2. Where applicable, the Federal and State accessibility for persons with disability standards:
A. Food service in all schools, including food service facilities, must comply with the following statutory and regulatory provisions relating to food protection including, but not limited to:
A. Schools must have a designated health room(s) to be utilized for health services. The room(s) must be equipped with no less than the following accommodations:
1. Within the health room:
2. Either within or adjacent to the health room:
3. Either within or accessible to the health room on the same floor of the building:
A. The premises of each school must include an appropriate number of hand washing facilities, toilets, and drinking fountains for all students and school personnel and must be maintained in a working and sanitary condition as determined by RIDOH and in accordance with the most recent version of the Code of Federal Regulations of the Division of Occupational Safety, R.I. Department of Labor and Training.
2. Toilets: At a minimum, the following ratios of toilets must be accessible to students:
| Type of School | Minimum Ratio of Toilets per Student | |
| Boys | Girls | |
| Elementary School | 1:40 | 1:35 |
| Secondary School | 1:75Urinals 1:30 | 1:45 |
A. Each school building must be furnished with an adequate supply of potable water in accordance with Part 50-05-1 of this Title, Public Drinking Water.
B. A community water system must be used as the source of supply where available.
School buildings, school campus, and all facilities used by a school, are subject to the provisions of R.I. Gen. Laws Chapters 23-20.9 entitled “Smoking in Schools” and Chapter 23-20.10 the “Public Health and Workplace Safety Act”.
The school district of each city, town, and regional school department is required to conduct an assessment every three (3) years to examine the safety of each school building in accordance with R.I. Gen Laws § 16-21-23(a).
The school committee or superintendent of each city, town, and regional school department is required to appoint a school safety team and a school crisis response team in accordance with R.I. Gen. Laws §§ 16-21-23(b) through (c).
A. In accordance with R.I. Gen. Laws § 16-21-23(b), the school committee of each city, town, and regional school department is required to adopt a comprehensive school safety plan that addresses preparedness, response and recovery and meets the policy and procedure requirements in R.I. Gen. Laws § 16-21-24.
1. The school safety plan must include best practices and relevant provisions of the current State model plan as published by RIDE including:
3. The school committee is required to review and update the school safety plans by November 1 of each year in accordance with R.I. Gen. Laws § 16-21-25.
A. All schools are required to have policies prohibiting possession of firearms and other weapons and imposing penalties for such possession in conformity with R.I. Gen. Laws § 16-21-18 and the “Gun Free Schools Act,” 20 U.S.C. § 8921 et seq.
A. All schools are required to have policies regarding possession of alcohol and other drugs and must have on-going prevention activities and programs as supported by the “Safe and Drug-Free Schools and Communities Act,” 20 U.S.C. § 7101 et seq.
A. All recreation facilities and areas, including gymnasiums, playgrounds, and athletic fields must be maintained and operated in a safe manner, including, at a minimum, the following provisions:
A. Each school is required to develop written procedures or protocols to reduce the risk of motor vehicle injuries and exposure to motor vehicle exhaust fumes among students. These procedures must be reviewed annually by school representatives and local police authorities and must address no less than the following issues:
A. Special purpose areas of school facilities that must include, but not be limited to, the cafeteria, home economics laboratory, industrial arts and vocational laboratories, art rooms, and science laboratories must be in compliance with the following provisions:
5. Rhode Island Council on Elementary and Secondary Education’s Basic Education Program (BEP) 200-RICR-20-10-1.
D. The written chemical hygiene plan required by this Part must include a prohibition on the use of the chemicals listed below.
| Full Chemical Name | CAS # | Reference |
| 1-(2-tert-Butylperoxy isopropyl)-3-isopropenylbenzene | 96319-55-0 | 49 C.F.R. § 173.225 |
| 1-(o-Chlorophenyl)thiourea | 5344-82-1 | EPA Acutely Toxic (P Listed) |
| 1,1-Di-(tert-amylperoxy)cyclohexane | 15667-10-4 | 49 C.F.R. § 173.225 |
| 1,1-Di-(tert-butylperoxy)-3,3,5-trimethylcyclohexane | 6731-36-8 | 49 C.F.R. § 173.225 |
| 1,1-Di-(tert-butylperoxy)cyclohexane | 3006-86-8 | 49 C.F.R. § 173.225 |
| 1,1'-Diazoaminonaphthalene | DOT Forbidden | |
| 1,1-Dimethyl-3-hydroxybutylperoxyneoheptanoate | 49 C.F.R. § 173.225 | |
| 1,2,3-Propanetriol, trinitrate (R) | 55-63-0 | EPA Acutely Toxic (P Listed) |
| 1,2,4-butanetriol trinitrate | DOT Forbidden | |
| 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)- | 51-43-4 | EPA Acutely Toxic (P Listed) |
| 1,2-Diazidoethane | DOT Forbidden | |
| 1,2-Dibromo-3-Chloropropane | 96-12-8 | Reproductive Toxin, Select Carcinogen |
| 1,2-Propylenimine | 75-55-8 | EPA Acutely Toxic (P Listed) |
| 1,3,4 oxadiazole | IARC List of Known and Suspected Human Carcinogens | |
| 1,3-butadiene | 106-99-0 | OSHA Listed Chemicals |
| 1,3-Diazopropane | DOT Forbidden | |
| 1,3-dinitro-5,5-dimethyl hydantoin | DOT Forbidden | |
| 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime | 26419-73-8 | EPA Acutely Toxic (P Listed) |
| 1,4-Butanediol Dimethylsulfonate | 55-98-1 | Select Carcinogen |
| 1,7-octadine-3, 5-diyne-1, 8-dimethoxy-9-octadecynoic acid | DOT Forbidden | |
| 1,8-dihydroxy-2,4,5,7-tetranitroanthraquinone | DOT Forbidden | |
| 1,9-dinitroxy pentamethylene-2,4, 6,8-tetramine | DOT Forbidden | |
| 1-Acetyl-2-thiourea | 591-08-2 | EPA Acutely Toxic (P Listed) |
| 1-bromo-3-nitrobenzene | DOT Forbidden | |
| 2-(2-Hydroxyethoxy)-1-(pyrrolidin-1-yl)benzene-4-diazonium zinc chloride | 15005-97-7 | 49 C.F.R. § 173.224 |
| 2-(N,N-Ethoxycarbonylphenylamino)-3-methoxy-4-(N-methyl-N-cyclohexylamino)benzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 2-(N,N-Methylaminoethylcarbonyl)-4-(3,4-dimethyl-phenylsulphonyl)benzene diazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 2,2'-Azodi(2,4-dimethyl-4-methoxyvaleronitrile) | 49 C.F.R. § 173.224 | |
| 2,2'-Azodi(2,4-dimethylvaleronitrile) | 4419-11-8 | 49 C.F.R. § 173.224 |
| 2,2-Azodi(2-methylbutyronitrile) | 49 C.F.R. § 173.224 | |
| 2,2'-Azodi(ethyl 2- methylpropionate) | 49 C.F.R. § 173.224 | |
| 2,2'-Azodi(isobutyronitrile) | 78-67-1 | 49 C.F.R. § 173.224 |
| 2,2-Di-(4,4-di(tert-butylperoxy)cyclohexyl)propane | 1705-60-8 | 49 C.F.R. § 173.225 |
| 2,2-di-(4,4-di-tert-butylperoxycyclohexyl) propane | DOT Forbidden | |
| 2,2-Di-(tert-butylperoxy) butane | DOT Forbidden | |
| 2,2-di-(tert-Butylperoxy)butane | 2167-23-9 | 49 C.F.R. § 173.225 |
| 2,2-Di-(tert-butylperoxy)propane | 1705-60-8 | 49 C.F.R. § 173.225 |
| 2,2-Dihydroperoxypropane | 2614-76-8 | 49 C.F.R. § 173.225 |
| 2,2-dinitrostilbene | DOT Forbidden | |
| 2,4-Dinitrophenol | 51-28-5 | EPA Acutely Toxic (P Listed) |
| 2,5 Dimethyl 2,5 di-2-ethylhexanoylperoxyhexane | 49 C.F.R. § 173.225 | |
| 2,5-Diethoxy-4-(phenylsulphonyl)benzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 2,5-Diethoxy-4-2,5-Diethoxy-4-morpholinobenzenediazonium zinc chloride | 26123-91-1 | 49 C.F.R. § 173.224 |
| 2,5-Diethoxy-4-morpholinobenzenediazonium tetrafluoroborate | 4979-72-0 | 49 C.F.R. § 173.224 |
| 2,5-Diethoxy-4-morpholinobenzenediazonium zinc chloride | 26123-91-1 | 49 C.F.R. § 173.224 |
| 2,5-Dimethoxy-4-(4-methylphenylsulphony)benzene diazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 2,5-Dimethyl-2,5-di-(3,5,5-trimethylhexanoylperoxy)hexane | 49 C.F.R. § 173.225 | |
| 2,5-Dimethyl-2,5-di-(benzoylperoxy)hexane | 2618-77-1 | 49 C.F.R. § 173.225 |
| 2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane | 78-63-7 | 49 C.F.R. § 173.225 |
| 2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexyne-3 | 1068-27-5 | 49 C.F.R. § 173.225 |
| 2,5-dimethyl-2,5-dihydroperoxy hexane | DOT Forbidden | |
| 2,5-Dimethyl-2,5-dihydroperoxyhexane | 3025-88-5 | 49 C.F.R. § 173.225 |
| 2-acetylaminofluorene | 53-96-3 | OSHA Listed Chemicals |
| 2-Acetylaminofluorine | Select Carcinogen | |
| 2-Cyclohexyl-4,6-dinitrophenol | 131-89-5 | EPA Acutely Toxic (P Listed) |
| 2-Diazo-1-Naphthol-4-sulphochloride | 49 C.F.R. § 173.224 | |
| 2-Diazo-1-Naphthol-5-sulphochloride | 49 C.F.R. § 173.224 | |
| 2-Methyllactonitrile | 75-86-5 | EPA Acutely Toxic (P Listed) |
| 2-Propanone, 1-bromo- | 598-31-2 | EPA Acutely Toxic (P Listed) |
| 2-Propen-1-ol | 107-18-6 | EPA Acutely Toxic (P Listed) |
| 2-Propenal | 107-02-8 | EPA Acutely Toxic (P Listed) |
| 3(2H)-Isoxazolone, 5-(aminomethyl)- | 2763-96-4 | EPA Acutely Toxic (P Listed) |
| 3-(2-Hydroxyethoxy)-4-(pyrrolidin-1-yl)benzenediazonium zinc chloride | 15005-97-7 | 49 C.F.R. § 173.224 |
| 3,3,6,6,9,9-Hexamethyl-1,2,4,5-tetraoxacyclononane | 22397-33-7 | 49 C.F.R. § 173.225 |
| 3,3-dichlorobenzidine | 91-94-1 | OSHA Listed Chemicals |
| 3-3'-Dichlorobenzidine | 91-94-1 | Select Carcinogen |
| 3-Azido-1, 2-Propylene glycol dinitrate | DOT Forbidden | |
| 3-Chloro-4-diethylaminobenzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 3-Chloroperoxybenzoic acid | 937-14-4 | 49 C.F.R. § 173.225 |
| 3-Chloropropionitrile | 542-76-7 | EPA Acutely Toxic (P Listed) |
| 3-Isopropylphenyl N-methylcarbamate | 64-00-6 | EPA Acutely Toxic (P Listed) |
| 3-Methyl-4-(pyrrolidin-1-yl)benzenediazonium tetrafluoroborate | 36422-95-4 | 49 C.F.R. § 173.224 |
| 3-tert-Butylperoxy-3-phenylphthalide | 25251-51-8 | 49 C.F.R. § 173.225 |
| 4-(Benzyl(ethyl)amino)-3-ethoxybenzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 4-(Benzyl(methyl)amino)-3-ethoxybenzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 4,4'-Methylenebis (2-Chloroaniline) | 95-51-2 | Select Carcinogen |
| 4,6-Dinitro-o-cresol, & salts | 534-52-1 | EPA Acutely Toxic (P Listed) |
| 4-Aminobiphenyl | 92-67-1 | Select Carcinogen |
| 4-Aminopyridine | 504-24-5 | EPA Acutely Toxic (P Listed) |
| 4-bromo-1, 2-dinitrobenzene | DOT Forbidden | |
| 4-Dimethylamino-6-(2-dimethylaminoethoxy)toluene-2-diazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 4-Dimethylaminoazobenzene | 60-11-7 | Select Carcinogen |
| 4-Dipropylaminobenzenediazonium zinc chloride | 49 C.F.R. § 173.224 | |
| 4-Methylbenzenesulphonylhydrazide | 49 C.F.R. § 173.224 | |
| 4-Nitrobiphenyl | 92-93-3 | Select Carcinogen |
| 4-Nitrosophenol | 104-91-6 | 49 C.F.R. § 173.224 |
| 4-Pyridinamine | EPA Acutely Toxic (P Listed) | |
| 5-(Aminomethyl)-3-isoxazolol | 2763-96-4 | EPA Acutely Toxic (P Listed) |
| 5-Azido-1-hydroxy tetrazole | DOT Forbidden | |
| 5-Mercaptotetrazol-1-acetic acid | 57658-36-3 | DOT Explosive |
| 5-nitrobenzotriazol | 169796-98-9 | DOT Explosive |
| 7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate | 1563-66-2 | EPA Acutely Toxic (P Listed) |
| 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid | 145-73-3 | EPA Acutely Toxic (P Listed) |
| A-alpha-C [2-amino-9H-pyrido[2,3-b]indole] | IARC List of Known and Suspected Human Carcinogens | |
| Acetal | 105-57-7 | Peroxidizable |
| Acetaldehyde | 75-07-0 | Reproductive Toxin |
| Acetaldehyde, chloro- | 107-20-0 | EPA Acutely Toxic (P Listed) |
| Acetamide, 2-fluoro- | 640-19-7 | EPA Acutely Toxic (P Listed) |
| Acetamide, N-(aminothioxomethyl)- | 591-08-2 | EPA Acutely Toxic (P Listed) |
| Acetic acid, fluoro-, sodium salt | 62-74-8 | EPA Acutely Toxic (P Listed) |
| Acetyl acetone peroxide | 37187-22-7 | 49 C.F.R. § 173.225 |
| Acetyl benzoyl peroxide | 644-31-5 | 49 C.F.R. § 173.225 |
| Acetyl cyclohexanesulfonyl peroxide | 3179-56-4 | 49 C.F.R. § 173.225 |
| acetyl peroxide | 110-22-5 | DOT Forbidden |
| acetylaminofluorene, 2- | IARC List of Known and Suspected Human Carcinogens | |
| acetylene silver nitrate | 7761-88-8 | DOT Forbidden |
| Acrolein | 107-02-8 | EPA Acutely Toxic (P Listed) |
| Acrylamide | 79-06-1 | Select Carcinogen |
| Acrylonitrile | 107-13-1 | Select Carcinogen |
| actinomycin D | IARC List of Known and Suspected Human Carcinogens | |
| adriamycin [doxorubicin] | IARC List of Known and Suspected Human Carcinogens | |
| AF-2 [2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] | IARC List of Known and Suspected Human Carcinogens | |
| Aflatoxin | 1402-68-2 | Select Carcinogen |
| Aflatoxin B1 | 1162-65-8 | Select Carcinogen |
| Aflatoxin B2 | 7220-81-7 | Select Carcinogen |
| Aflatoxin G1 | 1165-39-5 | Select Carcinogen |
| Aflatoxin G2 | 7241-98-7 | Select Carcinogen |
| Aflatoxin M1 | 6795-23-9 | Select Carcinogen |
| agaritine | IARC List of Known and Suspected Human Carcinogens | |
| Aldicarb | 116-06-3 | EPA Acutely Toxic (P Listed) |
| Aldicarb sulfone. | 1646-88-4 | EPA Acutely Toxic (P Listed) |
| Aldrin | 309-00-2 | EPA Acutely Toxic (P Listed) |
| Allyl alcohol | 107-18-6 | EPA Acutely Toxic (P Listed) |
| Allyl isothiocyanate | IARC List of Known and Suspected Human Carcinogens | |
| Allyl isovalerate | IARC List of Known and Suspected Human Carcinogens | |
| alpha,alpha-Dimethylphenethylamine | 122-09-8 | EPA Acutely Toxic (P Listed) |
| Alpha-Naphthylamine | 134-32-7 | Select Carcinogen |
| Alpha-Naphthylthiourea | 86-88-4 | EPA Acutely Toxic (P Listed) |
| Aluminum phosphide (R,T) | 20859-73-8 | EPA Acutely Toxic (P Listed) |
| amino-2-methylanthraquinone, 1- | IARC List of Known and Suspected Human Carcinogens | |
| amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | IARC List of Known and Suspected Human Carcinogens | |
| amino-5-nitrothiazole, 2- | IARC List of Known and Suspected Human Carcinogens | |
| aminoanthraquinone, 2- | IARC List of Known and Suspected Human Carcinogens | |
| aminoazobenzene, p- | IARC List of Known and Suspected Human Carcinogens | |
| aminoazotoluene, o- [solvent yellow 3] | IARC List of Known and Suspected Human Carcinogens | |
| aminobipheny, 4- | IARC List of Known and Suspected Human Carcinogens | |
| amitrole | IARC List of Known and Suspected Human Carcinogens | |
| Ammonium azide | DOT Forbidden | |
| Ammonium bromate | DOT Forbidden | |
| Ammonium chlorate | 10192-29-7 | DOT Forbidden |
| Ammonium fulminate | DOT Forbidden | |
| Ammonium nitrate | 6484-52-2 | DOT Explosive |
| Ammonium nitrite | DOT Forbidden | |
| Ammonium perchlorate | 7790-98-9 | DOT Explosive |
| Ammonium permanganate | DOT Forbidden | |
| Ammonium picrate (R) | 131-74-8 | EPA Acutely Toxic (P Listed) |
| Ammonium vanadate | 7803-55-6 | EPA Acutely Toxic (P Listed) |
| androgenic (anabolic) steroids | IARC List of Known and Suspected Human Carcinogens | |
| aniline | IARC List of Known and Suspected Human Carcinogens | |
| anisidine hydrochloride, o- | IARC List of Known and Suspected Human Carcinogens | |
| anisidine, o- | IARC List of Known and Suspected Human Carcinogens | |
| anlagesic mixtures containing phenacetin | IARC List of Known and Suspected Human Carcinogens | |
| anthanthrene | IARC List of Known and Suspected Human Carcinogens | |
| antimony sulfide | 1345-04-6 | DOT Forbidden |
| aramite | IARC List of Known and Suspected Human Carcinogens | |
| Argentate(1-), bis(cyano-C)-, potassium | 506-61-6 | EPA Acutely Toxic (P Listed) |
| Arsenic | 7440-38-2 | Reproductive Toxin, Select Carcinogen |
| Arsenic acid H3 AsO4 | 7778-39-4 | EPA Acutely Toxic (P Listed) |
| Arsenic oxide As2 O3 | 1327-53-3 | EPA Acutely Toxic (P Listed) |
| Arsenic oxide As2 O5 | 1303-28-2 | EPA Acutely Toxic (P Listed) |
| Arsenic pentoxide | 1303-28-2 | EPA Acutely Toxic (P Listed) |
| Arsenic sulfide | 56320-22-0 | DOT Forbidden |
| Arsenic trioxide | 1327-53-3 | EPA Acutely Toxic (P Listed) |
| Arsine | 7784-42-1 | Acutely Toxic |
| Arsine, diethyl- | 692-42-2 | EPA Acutely Toxic (P Listed) |
| Arsonous dichloride, phenyl- | 696-28-6 | EPA Acutely Toxic (P Listed) |
| Asbestos | 1332-21-4 | Select Carcinogen |
| ascaridole | DOT Forbidden | |
| auramine | IARC List of Known and Suspected Human Carcinogens | |
| azacitidine | IARC List of Known and Suspected Human Carcinogens | |
| azaserine | IARC List of Known and Suspected Human Carcinogens | |
| Azathioprine | Select Carcinogen | |
| azaurolic acid | DOT Forbidden | |
| azido guanidine picrate | DOT Forbidden | |
| azidodithiocarbonic acid | DOT Forbidden | |
| azidoethyl nitrate | DOT Forbidden | |
| Aziridine | 151-56-4 | EPA Acutely Toxic (P Listed) |
| Aziridine, 2-methyl- | 75-55-8 | EPA Acutely Toxic (P Listed) |
| Azodi(hexahydrobenzonitrile) | 2094-98-6 | 49 C.F.R. § 173.224 |
| Azodicarbonamide formulation | 123-77-3 | 49 C.F.R. § 173.224 |
| Barium azide | 18810-58-7 | DOT Explosive |
| Barium Chromate | 10294-40-3 | Select Carcinogen |
| Barium cyanide | 542-62-1 | EPA Acutely Toxic (P Listed) |
| barium styphnate | 20236-55-9 | DOT Explosive |
| benz[a]anthracene | IARC List of Known and Suspected Human Carcinogens | |
| benz[c]acridine | IARC List of Known and Suspected Human Carcinogens | |
| Benzenamine, 4-chloro- | 106-47-8 | EPA Acutely Toxic (P Listed) |
| Benzenamine, 4-nitro- | 100-01-6 | EPA Acutely Toxic (P Listed) |
| Benzene | 71-43-2 | Reproductive Toxin, Select Carcinogen |
| Benzene diazonim chloride | DOT Forbidden | |
| Benzene sulphohydrazide | 80-17-1 | 49 C.F.R. § 173.224 |
| Benzene triozonide | DOT Forbidden | |
| Benzene, (chloromethyl)- | 100-44-7 | EPA Acutely Toxic (P Listed) |
| Benzene-1,3-disulphohydrazide | 49 C.F.R. § 173.224 | |
| Benzeneethanamine, alpha,alpha-dimethyl- | 122-09-8 | EPA Acutely Toxic (P Listed) |
| Benzenethiol | 108-98-5 | EPA Acutely Toxic (P Listed) |
| Benzidine | 92-87-5 | Select Carcinogen |
| benzo[a]pyrene | IARC List of Known and Suspected Human Carcinogens | |
| benzo[b]fluoranthene | IARC List of Known and Suspected Human Carcinogens | |
| benzo[j]fluoranthene | IARC List of Known and Suspected Human Carcinogens | |
| benzo[k]fluoroanthene | IARC List of Known and Suspected Human Carcinogens | |
| benzotrichloride | IARC List of Known and Suspected Human Carcinogens | |
| Benzoyl (3-methylbenzoyl) peroxide | 214425-85-1 | 49 C.F.R. § 173.225 |
| Benzoyl azide | DOT Forbidden | |
| Benzyl chloride | 100-44-7 | EPA Acutely Toxic (P Listed) |
| Benzyl violet 4B | IARC List of Known and Suspected Human Carcinogens | |
| beryllium & beryllium compounds (e.g. oxide or sulfate) | IARC List of Known and Suspected Human Carcinogens | |
| Beryllium powder | 7440-41-7 | EPA Acutely Toxic (P Listed) |
| Beta-naphthylamine | 91-59-8 | OSHA Listed Chemicals |
| Beta-Propiolactone | 57-57-8 | Select Carcinogen |
| bieomycins | IARC List of Known and Suspected Human Carcinogens | |
| biphenyl triozonide | DOT Forbidden | |
| bis(chloroethyl) nitrosourea [BCNU] | IARC List of Known and Suspected Human Carcinogens | |
| bis(chloromethyl)ether [BCME] | IARC List of Known and Suspected Human Carcinogens | |
| bitumens, extracts of steam and air refined | IARC List of Known and Suspected Human Carcinogens | |
| bromine azide | 13973-87-0 | DOT Forbidden |
| Bromoacetone | 598-31-2 | EPA Acutely Toxic (P Listed) |
| bromosilane | DOT Forbidden | |
| Brucine | 357-57-3 | EPA Acutely Toxic (P Listed) |
| Butadiene | 106-99-0 | Peroxidizable |
| butadiene, 1,3- | IARC List of Known and Suspected Human Carcinogens | |
| butylated hydroxyanisole [BHA] | IARC List of Known and Suspected Human Carcinogens | |
| butyrolactone, beta- | IARC List of Known and Suspected Human Carcinogens | |
| C.I. basic red 9 monohydrochloride | IARC List of Known and Suspected Human Carcinogens | |
| Cadmium and cadmium compounds | Reproductive Toxin | |
| Calcium cyanide | 592-01-8 | EPA Acutely Toxic (P Listed) |
| captan | 133-06-2 | IARC List of Known and Suspected Human Carcinogens |
| Carbamic acid, [(dibutylamino)- thio]methyl-, 2,3-dihydro-2,2-dimethyl- 7-benzofuranyl ester | 55285-14-8 | EPA Acutely Toxic (P Listed) |
| Carbamic acid, dimethyl-, 1-[(dimethyl-amino)carbonyl]- 5-methyl-1H- pyrazol-3-yl ester | 644-64-4 | EPA Acutely Toxic (P Listed) |
| Carbamic acid, dimethyl-, 3-methyl-1- (1-methylethyl)-1H- pyrazol-5-yl ester | 119-38-0 | EPA Acutely Toxic (P Listed) |
| Carbamic acid, methyl-, 3-methylphenyl ester | 1129-41-5 | EPA Acutely Toxic (P Listed) |
| carbazole | 86-74-8 | IARC List of Known and Suspected Human Carcinogens |
| Carbofuran | 1563-66-2 | EPA Acutely Toxic (P Listed) |
| Carbon Disulfide | 75-15-0 | Reproductive Toxin |
| Carbon tetrachloride | 56-23-5 | IARC List of Known and Suspected Human Carcinogens |
| Carbonic dichloride | 75-15-0 | EPA Acutely Toxic (P Listed) |
| Carbosulfan | 55285-14-8 | EPA Acutely Toxic (P Listed) |
| carrageenan | 9000-07-1 | IARC List of Known and Suspected Human Carcinogens |
| Chloramabucil | Select Carcinogen | |
| chloramphenicol | 56-75-7 | IARC List of Known and Suspected Human Carcinogens |
| chlorbenzilat | 510-15-6 | IARC List of Known and Suspected Human Carcinogens |
| chlordane | 57-74-9 | IARC List of Known and Suspected Human Carcinogens |
| chlordecone [kepone] | 143-50-0 | IARC List of Known and Suspected Human Carcinogens |
| chlorendic acid | 115-28-6 | IARC List of Known and Suspected Human Carcinogens |
| chlorinated, alpha- toluenes | (benzal chloride [98-87-3], benzotrichloride [98-07-7], benzyl chloride [100-44-7]) and benzoyl chloride [98-88-4] | IARC List of Known and Suspected Human Carcinogens |
| Chlorine azide | DOT Forbidden | |
| Chlorine dioxide | 10049-04-4 | DOT Forbidden |
| Chlorine Gas | 7782-50-5 | Acutely Toxic |
| chlormadinone acetate | 302-22-7 | IARC List of Known and Suspected Human Carcinogens |
| Chlornaphazine | Select Carcinogen | |
| chlornaphazine [n,n-bis(2-chloroethyl)-2-naphthylamine] | 494-03-1 | IARC List of Known and Suspected Human Carcinogens |
| Chloroacetaldehyde | 107-20-0 | EPA Acutely Toxic (P Listed) |
| chloroacetone | 78-95-5 | DOT Forbidden |
| chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-(2- [CCNU] | IARC List of Known and Suspected Human Carcinogens | |
| chloroform | 67-66-3 | IARC List of Known and Suspected Human Carcinogens |
| Chloromethyl ethyl ether | 3188-13-4 | IARC List of Known and Suspected Human Carcinogens |
| Chloromethyl Methyl Ether | Select Carcinogen | |
| chloro-o-phenylenediamine, 4- | 95-83-0 | IARC List of Known and Suspected Human Carcinogens |
| chloro-o-toluidine, p- | 95-69-2 | IARC List of Known and Suspected Human Carcinogens |
| chloro-o-toluidine, p- and its HCl salt | IARC List of Known and Suspected Human Carcinogens | |
| chlorophenols | IARC List of Known and Suspected Human Carcinogens | |
| chlorophenoxy herbicides | IARC List of Known and Suspected Human Carcinogens | |
| Chloroprene | 126-99-8 | Peroxidizable |
| chloroprene | 126-99-8 | DOT Forbidden |
| chlorothalonil | 1897-45-6 | IARC List of Known and Suspected Human Carcinogens |
| chlorozotocin | 54749-90-5 | IARC List of Known and Suspected Human Carcinogens |
| cholesterol | 57-88-5 | IARC List of Known and Suspected Human Carcinogens |
| Chromium and chromium compounds | 7440-47-3 | Select Carcinogen |
| chrysene | 218-01-9 | IARC List of Known and Suspected Human Carcinogens |
| cinnamyl anthranilate | 87-29-6 | IARC List of Known and Suspected Human Carcinogens |
| cisplatin [trade name=platinol] | 15663-27-1 | IARC List of Known and Suspected Human Carcinogens |
| citrus red no. 2 | 6358-53-8 | IARC List of Known and Suspected Human Carcinogens |
| clofibrate | 637-07-0 | IARC List of Known and Suspected Human Carcinogens |
| coal tar pitch volatiles | IARC List of Known and Suspected Human Carcinogens | |
| Copper acetylide | DOT Forbidden | |
| Copper amine azide | DOT Forbidden | |
| Copper cyanide | 544-92-3 | EPA Acutely Toxic (P Listed) |
| Copper tetramine nitrate | DOT Forbidden | |
| creosotes | IARC List of Known and Suspected Human Carcinogens | |
| cresidine, p- | 120-71-8 | IARC List of Known and Suspected Human Carcinogens |
| Cumene | 98-82-8 | Peroxidizable |
| Cumyl hydroperoxide | 80-15-9 | 49 C.F.R. § 173.225 |
| Cumyl peroxyneodecanoate | 26748-47-0 | 49 C.F.R. § 173.225 |
| Cumyl peroxypivalate | 23383-59-7 | 49 C.F.R. § 173.225 |
| cupferron | 135-20-6 | IARC List of Known and Suspected Human Carcinogens |
| Cyanides (soluble cyanide salts), not otherwise specified | EPA Acutely Toxic (P Listed) | |
| Cyanogen | 460-19-5 | EPA Acutely Toxic (P Listed) |
| Cyanogen chloride | 506-77-4 | EPA Acutely Toxic (P Listed) |
| cyanuric triazide | DOT Forbidden | |
| cycasin [methylazoxmethanol] | 14901-08-7 | IARC List of Known and Suspected Human Carcinogens |
| cyclamates | 139-05-9 | IARC List of Known and Suspected Human Carcinogens |
| Cyclohexanone peroxide(s) [as a paste] | 78-18-2 | 49 C.F.R. § 173.225 |
| Cyclohexanone peroxide(s) [as a solution] | 12262-58-7 | 49 C.F.R. § 173.225 |
| Cyclohexene | 110-83-8 | Peroxidizable |
| cyclopenta[cd]pyrene | 27208-37-3 | IARC List of Known and Suspected Human Carcinogens |
| Cyclopentene | 142-29-0 | Peroxidizable |
| Cyclophosphamide | 50-18-0 | Select Carcinogen |
| cyclosporin | 79217-60-0 | IARC List of Known and Suspected Human Carcinogens |
| cyclotetramethylene tetranitramine | DOT Forbidden | |
| cyclotetramethylenetetranitramine | 2691-41-0 | DOT Explosive |
| D, 2,4- (salts and esters) e.g. phenolyacetic acid | 94-75-7 | IARC List of Known and Suspected Human Carcinogens |
| dacarbazine [trade name=DIC or DTIC] | 4342-03-4 | IARC List of Known and Suspected Human Carcinogens |
| danthron | 117-10-2 | IARC List of Known and Suspected Human Carcinogens |
| dapsone | 80-08-0 | IARC List of Known and Suspected Human Carcinogens |
| daunomycin [daunorubicin] | 20830-81-3 | IARC List of Known and Suspected Human Carcinogens |
| DDT | 50-29-3 | IARC List of Known and Suspected Human Carcinogens |
| decabromodiphenyl oxide | 1163-19-5 | IARC List of Known and Suspected Human Carcinogens |
| Decalin | 91-17-8 | Peroxidizable |
| Di-(1-hydroxycyclohexyl)peroxide | 2407-94-5 | 49 C.F.R. § 173.225 |
| Di-(1-hydroxytetrazole) | DOT Forbidden | |
| Di-(2-ethoxyethyl)peroxydicarbonate | 52373-74-7 | 49 C.F.R. § 173.225 |
| Di-(2-ethylhexyl)peroxydicarbonate | 16111-62-9 | 49 C.F.R. § 173.225 |
| Di-(2-ethylhexyl)peroydicarbonate | 49 C.F.R. § 173.225 | |
| Di(2-ethylhexyl)phthalate | 117-81-7 | IARC List of Known and Suspected Human Carcinogens |
| Di-(2-methylbenzoyl)peroxide | 3034-79-5 | 49 C.F.R. § 173.225 |
| Di-(2-neodecanoylperoxyisopropyl)benzene | 49 C.F.R. § 173.225 | |
| Di-(2-phenoxyethyl)peroxydicarbonate | 41935-39-1 | 49 C.F.R. § 173.225 |
| Di-(2-tert-butylperoxyisopropyl)benzene | 279671-18-0 | 49 C.F.R. § 173.225 |
| Di-(3,5,5-trimethyl-1,2-dioxolanyl- 3)peroxide | 49 C.F.R. § 173.225 | |
| Di-(3,5,5-trimethylhexanoyl)peroxide | 49 C.F.R. § 173.225 | |
| Di-(3-methoxybutyl)peroxydicarbonate | 52238-68-3 | 49 C.F.R. § 173.225 |
| Di-(3-methylbenzoyl)peroxide | 96436-26-9 | 49 C.F.R. § 173.225 |
| Di-(4-methylbenzoyl)peroxide | 895-85-2 | 49 C.F.R. § 173.225 |
| Di-(4-tert-butylcyclohexyl)peroxydicarbonate | 15520-11-3 | 49 C.F.R. § 173.225 |
| Di-(beta-nitroxyethyl) ammonium nitrate | DOT Forbidden | |
| Di-(tert-butylperoxy) phthalate | DOT Forbidden | |
| Di-(tert-butylperoxy)phthalate | 2155-71-7 | 49 C.F.R. § 173.225 |
| Di-2,4-dichlorobenzoyl peroxide | 133-14-2 | 49 C.F.R. § 173.225 |
| Di-2,4-dichlorobenzoyl peroxide | DOT Forbidden | |
| Di-4-chlorobenzoyl peroxide | 94-17-7 | 49 C.F.R. § 173.225 |
| Diacetone alcohol peroxides | 54693-46-8 | 49 C.F.R. § 173.225 |
| Diacetyl peroxide | 110-22-5 | 49 C.F.R. § 173.225 |
| diacetylbenzidine, n,n'- | 613-35-4 | IARC List of Known and Suspected Human Carcinogens |
| Diacetylene | 446-86-6 | Peroxidizable |
| diallate | 2303-16-4 | IARC List of Known and Suspected Human Carcinogens |
| diaminoanisole sulfate, 2,4- | IARC List of Known and Suspected Human Carcinogens | |
| diaminoanisole, 2,4- | 615-05-4 | IARC List of Known and Suspected Human Carcinogens |
| diaminodiphenyl ether, 4,4'- | 101-80-4 | IARC List of Known and Suspected Human Carcinogens |
| diaminotoluene, 2,4- | 95-80-7 | IARC List of Known and Suspected Human Carcinogens |
| diazoaminotetrazole | DOT Forbidden | |
| Diazomethane | 334-88-3 | Acutely Toxic |
| diazonium nitrates | DOT Forbidden | |
| diazonium perchlorates | DOT Forbidden | |
| dibenz[a,c]anthracene | 215-58-7 | IARC List of Known and Suspected Human Carcinogens |
| dibenz[a,h]acridine | 226-36-8 | IARC List of Known and Suspected Human Carcinogens |
| dibenz[a,h]anthracene | 53-70-3 | IARC List of Known and Suspected Human Carcinogens |
| dibenz[a,j]acridine | 224-42-0 | IARC List of Known and Suspected Human Carcinogens |
| dibenz[a,j]anthracene | 224-41-9 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[a,e]fluoranthene | 5385-75-1 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[a,e]pyrene | 192-65-4 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[a,h]pyrene | 189-64-0 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[a,i]pyrene | 189-55-9 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[a,l]pyrene | 191-30-0 | IARC List of Known and Suspected Human Carcinogens |
| dibenzo[c,g]carbazole, 7H- | 194-59-2 | IARC List of Known and Suspected Human Carcinogens |
| Dibenzoyl peroxide | 94-36-0 | 49 C.F.R. § 173.225 |
| Dibenzyl peroxydicarbonate | 2144-45-8 | 49 C.F.R. § 173.225 |
| dibenzyl peroxydicarbonate | DOT Forbidden | |
| Diborane | 19287-45-7 | Acutely Toxic |
| dibromo-3-chloropropane, 1,2- [DBCP] | 96-12-8 | IARC List of Known and Suspected Human Carcinogens |
| dibromoacetylene | 624-61-3 | DOT Forbidden |
| dibromomethane, 1,2- [DBM] | IARC List of Known and Suspected Human Carcinogens | |
| Dicetyl peroxydicarbonate | 26322-14-5 | 49 C.F.R. § 173.225 |
| dichloro-4,4'-diaminodiphenyl ether, 3,3'- | 28434-86-8 | IARC List of Known and Suspected Human Carcinogens |
| dichloroacetylene | 7572-29-4 | DOT Forbidden |
| dichlorobenzene, 1,4- | 106-46-7 | IARC List of Known and Suspected Human Carcinogens |
| dichlorobenzidine, 3,3'- | 91-94-1 | IARC List of Known and Suspected Human Carcinogens |
| dichloroethane, 1,2- [EDC] [ethylene dichloride] | 107-06-2 | IARC List of Known and Suspected Human Carcinogens |
| dichloroethyl sulfide | DOT Forbidden | |
| dichloromethane | 75-09-2 | IARC List of Known and Suspected Human Carcinogens |
| Dichloromethyl ether | 542-88-1 | EPA Acutely Toxic (P Listed) |
| Dichlorophenylarsine | 696-28-6 | EPA Acutely Toxic (P Listed) |
| dichloropropane, 1,2- [propylene dichloride] | 78-87-5 | IARC List of Known and Suspected Human Carcinogens |
| dichloropropene, 1,3- | 542-75-6 | IARC List of Known and Suspected Human Carcinogens |
| dichlorovinylchloroarsine | DOT Forbidden | |
| dicofol | 115-32-2 | IARC List of Known and Suspected Human Carcinogens |
| Dicumyl peroxide | 80-43-3 | 49 C.F.R. § 173.225 |
| Dicyclohexyl peroxydicarbonate | 1561-49-5 | 49 C.F.R. § 173.225 |
| Dicyclopentadiene | 77-73-6 | Peroxidizable |
| Didecanoyl peroxide | 762-12-9 | 49 C.F.R. § 173.225 |
| Dieldrin | 60-57-1 | IARC List of Known and Suspected Human Carcinogens |
| Dieldrin | 60-57-1 | EPA Acutely Toxic (P Listed) |
| dienoestrol | 84-17-3 | IARC List of Known and Suspected Human Carcinogens |
| diepoxybutane | 1464-53-5 | IARC List of Known and Suspected Human Carcinogens |
| diethanol nitrosamine dinitrate | DOT Forbidden | |
| Diethyl Ether | 60-29-7 | Peroxidizable |
| Diethyl peroxydicarbonate | 14666-78-5 | 49 C.F.R. § 173.225 |
| Diethyl sulfate | 64-67-5 | IARC List of Known and Suspected Human Carcinogens |
| Diethylarsine | 692-42-2 | EPA Acutely Toxic (P Listed) |
| Diethylene glycol bis(allyl carbonate) + Diisopropylperoxydicarbonate | 49 C.F.R. § 173.224 | |
| Diethylene Glycol Dimethyl Ether | 11-96-6 | Peroxidizable |
| diethylene glycol dinitrate | 693-21-0 | DOT Forbidden |
| diethyleneglycol dinitrate | 628-96-6 | DOT Explosive |
| diethylgold bromide | DOT Forbidden | |
| diethylhydrazine, 1,2- OR n,n'-diethylhydrazine | 1615-80-1 | IARC List of Known and Suspected Human Carcinogens |
| Diethylnitrosamine | Select Carcinogen | |
| Diethyl-p-nitrophenyl phosphate | 311-45-5 | EPA Acutely Toxic (P Listed) |
| Diethylstilbestrol | 56-53-1 | Select Carcinogen |
| diglycidyl resorcinol ether | 101-90-6 | IARC List of Known and Suspected Human Carcinogens |
| dihydrosafrole | 94-58-6 | IARC List of Known and Suspected Human Carcinogens |
| diiodoacetylene | DOT Forbidden | |
| Diisobutyryl peroxide | 3437-84-1 | 49 C.F.R. § 173.225 |
| Diisopropyl peroxydicarbonate | 105-64-6 | 49 C.F.R. § 173.225 |
| Diisopropylbenzene dihydroperoxide | 29014-32-2 | 49 C.F.R. § 173.225 |
| diisopropylbenzene hydroperoxide | DOT Forbidden | |
| Diisopropylfluorophosphate (DFP) | 55-91-4 | EPA Acutely Toxic (P Listed) |
| Diisotridecyl peroxydicarbonate | 49 C.F.R. § 173.225 | |
| Dilauroyl peroxide | 105-74-8 | 49 C.F.R. § 173.225 |
| Dimethoate | 60-51-5 | EPA Acutely Toxic (P Listed) |
| dimethoxybenzidine, 3,3'- [o-dianisidine] | 119-90-4 | IARC List of Known and Suspected Human Carcinogens |
| Dimethyl Sulfate | 77-78-1 | Select Carcinogen |
| dimethylamino)methylimino]-5-[2-nitro-2-furyl)vinyl]- | IARC List of Known and Suspected Human Carcinogens | |
| dimethylaminoazobenzene (also 4 or para-) | 60-11-7 | IARC List of Known and Suspected Human Carcinogens |
| dimethylbenzidine, 3,3'- [o-toludine] | 119-93-7 | IARC List of Known and Suspected Human Carcinogens |
| dimethylcarbamoyl chloride | 79-44-7 | IARC List of Known and Suspected Human Carcinogens |
| dimethylhexane dihydroperoxide | DOT Forbidden | |
| dimethylhydrazine, 1,1- | 57-14-7 | IARC List of Known and Suspected Human Carcinogens |
| dimethylhydrazine, 1,2- | 540-73-8 | IARC List of Known and Suspected Human Carcinogens |
| Dimethylmercury * | 593-74-8 | Acutely Toxic |
| dimethylvinyl chloride | 513-37-1 | IARC List of Known and Suspected Human Carcinogens |
| Dimetilan | 644-64-4 | EPA Acutely Toxic (P Listed) |
| Dimyristyl peroxydicarbonate | 53220-22-7 | 49 C.F.R. § 173.225 |
| Di-n-butyl peroxydicarbonate | 16215-49-9 | 49 C.F.R. § 173.225 |
| Di-n-butyl peroxydicarbonate | DOT Forbidden | |
| dinitroglycoluril | 55510-04-8 | DOT Explosive |
| dinitrophenol | 51-28-5 | DOT Explosive |
| dinitropropylene glycol | DOT Forbidden | |
| dinitropyrene, 1,6- | 42397-64-8 | IARC List of Known and Suspected Human Carcinogens |
| dinitropyrene, 1,8- | 42397-65-9 | IARC List of Known and Suspected Human Carcinogens |
| dinitroresorcinol | 519-44-8 | DOT Explosive |
| dinitrosobenzene | 25550-55-4 | DOT Explosive |
| Di-n-nonanoyl peroxide | 762-13-0 | 49 C.F.R. § 173.225 |
| Di-n-octanoyl peroxide | 762-16-3 | 49 C.F.R. § 173.225 |
| Dinoseb | 88-85-7 | EPA Acutely Toxic (P Listed) |
| Di-n-propyl peroxydicarbonate | 16066-38-9 | 49 C.F.R. § 173.225 |
| Dioxane | 123-91-1 | Peroxidizable |
| dioxane, 1,4- | 123-91-1 | IARC List of Known and Suspected Human Carcinogens |
| Diperoxy azelaic acid | 1941-79-3 | 49 C.F.R. § 173.225 |
| Diperoxy dodecane diacid | 66280-55-5 | 49 C.F.R. § 173.225 |
| Diphenyloxide-4,4'-disulphohydrazide | 80-51-3 | 49 C.F.R. § 173.224 |
| Diphosphoramide, octamethyl- | 152-16-9 | EPA Acutely Toxic (P Listed) |
| Diphosphoric acid, tetraethyl ester | 107-49-3 | EPA Acutely Toxic (P Listed) |
| dipicryl sulfide | 2217-06-3 | DOT Explosive |
| Dipropionyl peroxide | 3248-28-0 | 49 C.F.R. § 173.225 |
| dipropionyl peroxide | DOT Forbidden | |
| direct black 38 | 1937-37-7 | IARC List of Known and Suspected Human Carcinogens |
| direct blue 6 | 2602-46-2 | IARC List of Known and Suspected Human Carcinogens |
| direct brown 95 | 16071-86-6 | IARC List of Known and Suspected Human Carcinogens |
| Di-sec-butyl peroxydicarbonate | 19910-65-7 | 49 C.F.R. § 173.225 |
| disperse blue 1 | 2475-45-8 | IARC List of Known and Suspected Human Carcinogens |
| Distearyl peroxydicarbonate | 52326-66-6 | 49 C.F.R. § 173.225 |
| Disuccinic acid peroxide | 123-23-9 | 49 C.F.R. § 173.225 |
| Disulfoton | 298-04-4 | EPA Acutely Toxic (P Listed) |
| Di-tert-amyl peroxide | 10508-09-5 | 49 C.F.R. § 173.225 |
| Di-tert-butyl peroxide | 110-05-4 | 49 C.F.R. § 173.225 |
| Di-tert-butyl peroxyazelate | 16580-06-6 | 49 C.F.R. § 173.225 |
| Dithiobiuret | 541-53-7 | EPA Acutely Toxic (P Listed) |
| Divinyl Ether | 109-86-4 | Peroxidizable |
| Endosulfan | 115-29-7 | EPA Acutely Toxic (P Listed) |
| Endothall | 145-73-3 | EPA Acutely Toxic (P Listed) |
| Endrin | 72-20-8 | EPA Acutely Toxic (P Listed) |
| Endrin, & metabolites | 72-20-8 | EPA Acutely Toxic (P Listed) |
| epichlorohydrin | 106-89-8 | IARC List of Known and Suspected Human Carcinogens |
| erionite | 66733-21-9 | IARC List of Known and Suspected Human Carcinogens |
| estradiol 17b | 50-28-2 | IARC List of Known and Suspected Human Carcinogens |
| estrone | 53-16-7 | IARC List of Known and Suspected Human Carcinogens |
| Ethanedinitrile | 460-19-5 | EPA Acutely Toxic (P Listed) |
| Ethanimidothioc acid, 2-(dimethylamino)-N-[[(methylamino) carbonyl]oxy]-2-oxo-, methyl ester | 23135-22-0 | EPA Acutely Toxic (P Listed) |
| Ethanimidothioic acid | 16752-77-5 | EPA Acutely Toxic (P Listed) |
| ethanol amine dinitrate | DOT Forbidden | |
| ethidium bromide | 1239-45-8 | Potent mutagen |
| ethinyloestradiol | 57-63-6 | IARC List of Known and Suspected Human Carcinogens |
| ethion | 563-12-2 | IARC List of Known and Suspected Human Carcinogens |
| Ethyl 3,3-di-(tert-amylperoxy)butyrate | 67567-23-1 | 49 C.F.R. § 173.225 |
| Ethyl 3,3-di-(tert-butylperoxy)butyrate | 55794-20-2 | 49 C.F.R. § 173.225 |
| Ethyl acrylate | 140-88-5 | IARC List of Known and Suspected Human Carcinogens |
| Ethyl cyanide | 107-12-0 | EPA Acutely Toxic (P Listed) |
| Ethyl hydroperoxide | DOT Forbidden | |
| Ethyl methanesulfonate | 62-50-0 | IARC List of Known and Suspected Human Carcinogens |
| Ethyl perchlorate | DOT Forbidden | |
| Ethylencimine | OSHA Listed Chemicals | |
| Ethylene diamine diperchlorate | DOT Forbidden | |
| Ethylene Dibromide | 106-93-4 | Select Carcinogen |
| Ethylene dichloride [1,2-dichloroethane] | 107-06-2 | IARC List of Known and Suspected Human Carcinogens |
| Ethylene Glycol Dimethyl Ether | 110-71-4 | Peroxidizable |
| Ethylene Glycol Monoethyl Ether | 110-80-5 | Peroxidizable, Reproductive Toxin |
| Ethylene Glycol Monomethyl Ether | 109-86-4 | Peroxidizable, Reproductive Toxin |
| Ethylene Oxide | 75-21-8 | Reproductive Toxin, Select Carcinogen |
| Ethylene thiourea | 96-45-7 | IARC List of Known and Suspected Human Carcinogens |
| Ethylenimine | 151-56-4 | Select Carcinogen |
| ethyl-n-nitrosourea, n- | 759-73-9 | IARC List of Known and Suspected Human Carcinogens |
| ethynodiol diacetate | 297-76-7 | IARC List of Known and Suspected Human Carcinogens |
| eugenol [oil of cloves] | 97-53-0 | IARC List of Known and Suspected Human Carcinogens |
| Famphur | 52-85-7 | EPA Acutely Toxic (P Listed) |
| Fluorine | 7782-41-4 | EPA Acutely Toxic (P Listed) |
| Fluoroacetamide | 640-19-7 | EPA Acutely Toxic (P Listed) |
| Fluoroacetic acid, sodium salt | 62-74-8 | EPA Acutely Toxic (P Listed) |
| fluorouracil | 51-21-8 | IARC List of Known and Suspected Human Carcinogens |
| Formaldehyde (Any solution or product with greater than .1%) | 50-00-0 | Select Carcinogen |
| Formetanate hydrochloride | 23422-53-9 | EPA Acutely Toxic (P Listed) |
| Formparanate | 17702-57-7 | EPA Acutely Toxic (P Listed) |
| formylhydrazino)-4-(nitro-2-furyl)thiazole, 2-(2- | 3570-75-0 | IARC List of Known and Suspected Human Carcinogens |
| Fulminic acid, mercury(2+) salt (R,T) | 628-86-4 | EPA Acutely Toxic (P Listed) |
| Furan | 110-00-9 | Peroxidizable |
| furfaltadone | IARC List of Known and Suspected Human Carcinogens | |
| glu-p-1(2-amino-6methyldipyrido[1,2-a:3',2'-d]imidazole | 67730-11-4 | IARC List of Known and Suspected Human Carcinogens |
| glu-p-2(2-aminodipyrido[1,2-a:3',2'-d]imidazole | 67730-10-3 | IARC List of Known and Suspected Human Carcinogens |
| glycerol gluconate trinitrate | DOT Forbidden | |
| glycerol-1, 3-dinitrate | DOT Forbidden | |
| glycidaldehyde | 765-34-4 | IARC List of Known and Suspected Human Carcinogens |
| griseofulvin | 126-07-8 | IARC List of Known and Suspected Human Carcinogens |
| guanyl nitrosaminoguanylidene hydrazine | DOT Explosive | |
| guanyl nitrosaminoguanylidene hydrazine | DOT Forbidden | |
| gyromitrin [acetaldeyde formylmethylhydrazone] | 16568-02-8 | IARC List of Known and Suspected Human Carcinogens |
| Heptachlor | 76-44-8 | EPA Acutely Toxic (P Listed) |
| hexachlorobutadiene | 87-68-3 | IARC List of Known and Suspected Human Carcinogens |
| hexachlorocyclohexane isomers [e.g. lindane] | IARC List of Known and Suspected Human Carcinogens | |
| Hexaethyl tetraphosphate | 757-58-4 | EPA Acutely Toxic (P Listed) |
| hexamethylene triperoxide diamine | DOT Forbidden | |
| Hexamethylphosphoramide | 680-31-9 | Select Carcinogen |
| hexanitroazoxy benzene | DOT Forbidden | |
| hexanitrodiphenyl urea | DOT Forbidden | |
| hexanitrodiphenylamine | 131-73-7 | DOT Explosive |
| hexanitrostilbene | 49850-40-0 | DOT Explosive |
| hydralazine | 86-54-4 | IARC List of Known and Suspected Human Carcinogens |
| Hydrazine | 302-01-2 | Select Carcinogen |
| hydrazine sulfate | 10034-93-2 | IARC List of Known and Suspected Human Carcinogens |
| Hydrazine, methyl- | 60-34-4 | EPA Acutely Toxic (P Listed) |
| Hydrazinecarbothioamide | 79-19-6 | EPA Acutely Toxic (P Listed) |
| hydrazobenzene | 122-66-7 | IARC List of Known and Suspected Human Carcinogens |
| Hydrocyanic Acid | 74-90-8 | EPA Acutely Toxic (P Listed) |
| Hydrocyanic Acid | 74-90-8 | DOT Forbidden |
| Hydrofluoric Acid | 7664-39-3 | Acutely Toxic |
| Hydrogen cyanide | 74-90-8 | EPA Acutely Toxic (P Listed) |
| Hydrogen Fluoride | 7664-39-3 | Acutely Toxic |
| Hydrogen phosphide | 7803-51-2 | EPA Acutely Toxic (P Listed) |
| Hyponitrous Acid | DOT Forbidden | |
| indeno[1,2,3-cd]pyrene | 193-39-5 | IARC List of Known and Suspected Human Carcinogens |
| Inorganic arsenic | OSHA Listed Chemicals | |
| iron dextran complex | 9004-66-4 | IARC List of Known and Suspected Human Carcinogens |
| Isodrin | 465-73-6 | EPA Acutely Toxic (P Listed) |
| Isolan | 119-38-0 | EPA Acutely Toxic (P Listed) |
| isonizid [isonicotinic acid hydrazide] | 54-85-3 | IARC List of Known and Suspected Human Carcinogens |
| Isopropyl Ether | 108-20-3 | Peroxidizable |
| Isopropylcumyl hydroperoxide | 57242-90-7 | 49 C.F.R. § 173.225 |
| isosafrole | 120-58-1 | IARC List of Known and Suspected Human Carcinogens |
| kepone [chlordecone] | 143-50-0 | IARC List of Known and Suspected Human Carcinogens |
| lasiocarpine | 303-34-4 | IARC List of Known and Suspected Human Carcinogens |
| Lead and lead compounds | 7439-92-1 | Reproductive Toxin |
| Lead mononitroresorcinate | 51317-24-9 | DOT Explosive |
| Lead styphnate | 15245-44-0 | DOT Explosive |
| lindane | 58-89-9 | IARC List of Known and Suspected Human Carcinogens |
| Manganese dimethyldithiocarbamate. | 15339-36-3 | EPA Acutely Toxic (P Listed) |
| Manganese, bis(dimethylcarbamodithioato-S,SŒ)- | 15339-36-3 | EPA Acutely Toxic (P Listed) |
| mannitol hexanitrate | 15825-70-4 | DOT Explosive |
| m-Cumenyl methylcarbamate | 64-00-6 | EPA Acutely Toxic (P Listed) |
| mea-alpha-c [2-amino-3-methyl-9H-pyrido[2,3-b]indole] | IARC List of Known and Suspected Human Carcinogens | |
| medroxyprogesterone acetate | 71-58-9 | IARC List of Known and Suspected Human Carcinogens |
| megestrol acetate | 595-33-5 | IARC List of Known and Suspected Human Carcinogens |
| Melphalan | 148-82-3 | Select Carcinogen |
| melphalan [alkeran] | 148-82-3 | IARC List of Known and Suspected Human Carcinogens |
| mercaptopurine, 6- | 50-44-2 | IARC List of Known and Suspected Human Carcinogens |
| Mercury | 7439-97-6 | Reproductive Toxin |
| Mercury fulminate | 628-86-4 | DOT Explosive |
| Mercury fulminate (R,T) | 628-86-4 | EPA Acutely Toxic (P Listed) |
| Mercury, (acetato-O)phenyl- | 62-38-4 | EPA Acutely Toxic (P Listed) |
| merphalan | 531-76-0 | IARC List of Known and Suspected Human Carcinogens |
| mestranol | 72-33-3 | IARC List of Known and Suspected Human Carcinogens |
| Methanamine, N-methyl-N-nitroso- | 62-75-9 | EPA Acutely Toxic (P Listed) |
| Methane, isocyanato- | 624-83-9 | EPA Acutely Toxic (P Listed) |
| Methane, oxybis[chloro- | 542-88-1 | EPA Acutely Toxic (P Listed) |
| Methane, tetranitro- (R) | 509-14-8 | EPA Acutely Toxic (P Listed) |
| Methanethiol, trichloro- | 75-70-7 | EPA Acutely Toxic (P Listed) |
| Methanimidamide, N,N-dimethyl-NŒ-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- | 23422-53-9 | EPA Acutely Toxic (P Listed) |
| Methanimidamide, N,N-dimethyl-NŒ-[3-[[(methylamino)-carbonyl]oxy]phenyl]-, monohydrochloride | 17702-57-7 | EPA Acutely Toxic (P Listed) |
| Methiocarb | 2032-65-7 | EPA Acutely Toxic (P Listed) |
| Methomyl | 16752-77-5 | EPA Acutely Toxic (P Listed) |
| methotrexate [trade name=mexate or folex] | 59-05-2 | IARC List of Known and Suspected Human Carcinogens |
| methoxsalen therapy [PUVA] | IARC List of Known and Suspected Human Carcinogens | |
| methoxypsoralen, 5- | 484-20-8 | IARC List of Known and Suspected Human Carcinogens |
| Methyl Acetylene | 74-99-7 | Peroxidizable |
| Methyl bromide | 74-83-9 | IARC List of Known and Suspected Human Carcinogens |
| Methyl chloride | 74-87-3 | IARC List of Known and Suspected Human Carcinogens |
| Methyl chloromethyl ether | 107-30-2 | OSHA Listed Chemicals |
| Methyl ethyl ketone peroxide | 1338-23-4 | 49 C.F.R. § 173.225 |
| Methyl Fluorosulfate | 421-20-5 | Acutely Toxic |
| Methyl hydrazine | 60-34-4 | EPA Acutely Toxic (P Listed) |
| Methyl hydrazine [monomethyl hydrazine] | 60-34-4 | IARC List of Known and Suspected Human Carcinogens |
| Methyl iodide | 74-88-4 | IARC List of Known and Suspected Human Carcinogens |
| Methyl Isobutyl Ketone | 108-10-1 | Peroxidizable |
| Methyl isobutyl ketone peroxide | 28056-59-9 | 49 C.F.R. § 173.225 |
| Methyl isocyanate | 624-83-9 | EPA Acutely Toxic (P Listed) |
| Methyl methanesulfonate | 66-27-3 | IARC List of Known and Suspected Human Carcinogens |
| Methyl parathion | 298-00-0 | EPA Acutely Toxic (P Listed) |
| methyl-1-nitroanthraquinone, 2- | 129-15-7 | IARC List of Known and Suspected Human Carcinogens |
| methylaziridine, 2- [propyleneimine] | 75-55-8 | IARC List of Known and Suspected Human Carcinogens |
| methylazoxymethanol and its acetate | 590-96-5 and 592-62-1 | IARC List of Known and Suspected Human Carcinogens |
| methylchrysene, 2- | 3351-32-4 | IARC List of Known and Suspected Human Carcinogens |
| methylchrysene, 3- | 3351-31-3 | IARC List of Known and Suspected Human Carcinogens |
| methylchrysene, 4- | 3351-30-2 | IARC List of Known and Suspected Human Carcinogens |
| methylchrysene, 5- | 3697-24-3 | IARC List of Known and Suspected Human Carcinogens |
| methylchrysene, 6- | 1705-85-7 | IARC List of Known and Suspected Human Carcinogens |
| Methylcyclohexanone peroxide | 11118-65-3 | 49C49 C.F.R. § 173.225 |
| Methylcyclopentane | 96-37-7 | Peroxidizable |
| methylenbis(n,n-dimethylaniline), 4,4'- | 101-61-1 | IARC List of Known and Suspected Human Carcinogens |
| Methylene bis(2-chloroaniline), 4,4'- [MOCA] | 101-14-4 | IARC List of Known and Suspected Human Carcinogens |
| Methylene bis(n,n-dimethyl)benzeneamine, 4,4'- | 101-61-1 | IARC List of Known and Suspected Human Carcinogens |
| Methylene chloride | 75-09-2 | OSHA Listed Chemicals |
| Methylenedianiline | 101-77-9 | OSHA Listed Chemicals |
| methylenedianiline, 4,4'- | 101-77-9 | IARC List of Known and Suspected Human Carcinogens |
| methyl-n'-nitro-n-nitrosoguanidine, n- [MNNG] | 70-25-7 | IARC List of Known and Suspected Human Carcinogens |
| methyl-n-nitrosourethane, n- | 615-53-2 | IARC List of Known and Suspected Human Carcinogens |
| methylthiouracil | 56-04-2 | IARC List of Known and Suspected Human Carcinogens |
| Metolcarb | 1129-41-6 | EPA Acutely Toxic (P Listed) |
| metronidazole | 443-48-1 | IARC List of Known and Suspected Human Carcinogens |
| Mexacarbamate | 315-18-4 | EPA Acutely Toxic (P Listed) |
| michler's ketone | 90-94-8 | IARC List of Known and Suspected Human Carcinogens |
| mirex | 2385-85-5 | IARC List of Known and Suspected Human Carcinogens |
| mitomycin C | 50-07-7 | IARC List of Known and Suspected Human Carcinogens |
| monocrotaline | 315-22-0 | IARC List of Known and Suspected Human Carcinogens |
| morpholinomethyl-3-[(5-nitrofurfurylidene)amino]-2- oxazolidinone, 5-( | 3795-88-8 | IARC List of Known and Suspected Human Carcinogens |
| Mustard Gas | Select Carcinogen | |
| myleran [1,4-butanediol dimethanesulfonate] | 55-98-1 | IARC List of Known and Suspected Human Carcinogens |
| N,N'- Dinitrosopentamethylenetetramine | 101-25-7 | 49 C.F.R. § 173.224 |
| N,N'-Dinitroso-N, N'-dimethyl-terephthalamide | 133-55-1 | 49 C.F.R. § 173.224 |
| N-[[(methylamino)carbonyl]oxy]-, methyl ester | EPA Acutely Toxic (P Listed) | |
| nafenopin | 3771-19-5 | IARC List of Known and Suspected Human Carcinogens |
| naphthylamine, 1- | 134-32-7 | IARC List of Known and Suspected Human Carcinogens |
| naphthylamine, 2- | 91-59-8 | IARC List of Known and Suspected Human Carcinogens |
| n-Butyl peroxydicarbonate | DOT Forbidden | |
| n-Butyl-4,4-di-(tert-butylperoxy)valerate | 995-33-5 | 49 C.F.R. § 173.225 |
| N-Formyl-2-(nitromethylene)-1,3-perhydrothiazine | 49 C.F.R. § 173.224 | |
| Nickel and some nickel compounds | 7440-02-0 | IARC List of Known and Suspected Human Carcinogens |
| Nickel Carbonyl | 13463-39-3 | Acutely Toxic, Select Carcinogen |
| Nickel carbonyl Ni(CO)4, (T-4)- | 13463-39-3 | EPA Acutely Toxic (P Listed) |
| Nickel cyanide | 557-19-7 | EPA Acutely Toxic (P Listed) |
| Nickel cynaide Ni(CN)2 | 557-19-8 | EPA Acutely Toxic (P Listed) |
| Nicotine, & salts | 54-11-5 | EPA Acutely Toxic (P Listed) |
| nifuradene(1-[(5-nitrofurfurylidene)amino]-2-imidazolinone) | IARC List of Known and Suspected Human Carcinogens | |
| niridazole | 61-57-4 | IARC List of Known and Suspected Human Carcinogens |
| nithiazide | 139-94-6 | IARC List of Known and Suspected Human Carcinogens |
| Nitric oxide | 10102-43-9 | EPA Acutely Toxic (P Listed) |
| nitrilotriacetic acid | 139-13-9 | IARC List of Known and Suspected Human Carcinogens |
| nitro urea | 556-89-8 | DOT Explosive |
| nitro-2-furyl)-2-thiazolyl]acetamide, n-[4-(5- | 531-82-8 | IARC List of Known and Suspected Human Carcinogens |
| nitroacenaphthene, 5- | 602-87-9 | IARC List of Known and Suspected Human Carcinogens |
| nitroanisole, o- | 91-23-6 | IARC List of Known and Suspected Human Carcinogens |
| nitrobiphenyl, 4- | 92-93-3 | IARC List of Known and Suspected Human Carcinogens |
| nitrocellulose | 9004-70-0 | DOT Explosive |
| nitrochrysene, 6- | 7496-02-8 | IARC List of Known and Suspected Human Carcinogens |
| nitrofen | 1836-75-5 | IARC List of Known and Suspected Human Carcinogens |
| Nitrogen dioxide | 10102-44-0 | EPA Acutely Toxic (P Listed) |
| Nitrogen mustard [trade name=mustargen] | 51-75-2 | IARC List of Known and Suspected Human Carcinogens |
| Nitrogen mustard n-oxide | 126-85-2 | IARC List of Known and Suspected Human Carcinogens |
| Nitrogen oxide NO | 10102-43-9 | EPA Acutely Toxic (P Listed) |
| Nitrogen oxide NO2 | 10102-44-0 | EPA Acutely Toxic (P Listed) |
| nitrogen trichloride | 10025-85-1 | DOT Forbidden |
| nitroglycerin | 55-63-0 | DOT Explosive |
| Nitroglycerine (R) | 55-63-0 | EPA Acutely Toxic (P Listed) |
| nitroguanidine | 556-88-7 | DOT Explosive |
| nitro-ortho-anisidine, 5- | 99-59-2 | IARC List of Known and Suspected Human Carcinogens |
| nitropropane, 2- | 25322-01-4 | IARC List of Known and Suspected Human Carcinogens |
| nitropyrene, 1- | 5522-43-0 | IARC List of Known and Suspected Human Carcinogens |
| nitropyrene, 4- | IARC List of Known and Suspected Human Carcinogens | |
| nitrosoamines (chemical name includes nitroso) | IARC List of Known and Suspected Human Carcinogens | |
| nitrosodiethanolamine, n- | IARC List of Known and Suspected Human Carcinogens | |
| nitrosodiethylamine, n- | 55-18-5 | IARC List of Known and Suspected Human Carcinogens |
| nitrosodimethylamine, p- | 62-75-9 | IARC List of Known and Suspected Human Carcinogens |
| nitrosodi-n-butylamine, n- | IARC List of Known and Suspected Human Carcinogens | |
| nitrosodi-n-propylamine, n- | IARC List of Known and Suspected Human Carcinogens | |
| nitrosomethylamino)-1-(3-pyrdyl)-1-butanone, 4-(n- | 64091-91-4 | IARC List of Known and Suspected Human Carcinogens |
| nitrosomethylamino)propionitrile, 3-(n- | 60153-49-3 | IARC List of Known and Suspected Human Carcinogens |
| nitrosomethylethylamine, n- | 10595-95-6 | IARC List of Known and Suspected Human Carcinogens |
| nitrosomethylvinylamine, n- | 4549-40-0 | IARC List of Known and Suspected Human Carcinogens |
| nitrosomorpholine, n- | 59-89-2 | IARC List of Known and Suspected Human Carcinogens |
| nitroso-n-ethylurea, n- | 759-73-9 | IARC List of Known and Suspected Human Carcinogens |
| nitroso-n-methylurea, n- | 684-93-5 | IARC List of Known and Suspected Human Carcinogens |
| nitrosonornicotine, n- | 80508-23-2 | IARC List of Known and Suspected Human Carcinogens |
| nitrosopiperidine, n- | 100-75-4 | IARC List of Known and Suspected Human Carcinogens |
| nitrosopyrrolidine, n- | 930-55-2 | IARC List of Known and Suspected Human Carcinogens |
| nitrososarcosine, n- | 13256-22-9 | IARC List of Known and Suspected Human Carcinogens |
| nitrostarch | 9056-38-6 | DOT Explosive |
| nitrotriazolone | DOT Explosive | |
| n-n'-Dichlorazodicarbonamidine | DOT Forbidden | |
| N-Nitrosodimethylamine | 62-75-9 | EPA Acutely Toxic (P Listed) |
| N-Nitrosomethylvinylamine | 4549-40-0 | EPA Acutely Toxic (P Listed) |
| norethisterone | 68-22-4 | IARC List of Known and Suspected Human Carcinogens |
| norethynodrel | 68-23-5 | IARC List of Known and Suspected Human Carcinogens |
| O,O-Diethyl O-pyrazinyl phosphorothioate | 297-97-2 | EPA Acutely Toxic (P Listed) |
| O-[(methylamino)carbonyl]oxime | EPA Acutely Toxic (P Listed) | |
| O-[4-[(dimethylamino)sulfonyl]phenyl] O,O-dimethyl ester | EPA Acutely Toxic (P Listed) | |
| ochratoxin A | 303-47-9 | IARC List of Known and Suspected Human Carcinogens |
| Octamethylpyrophosphoramide | 152-16-9 | EPA Acutely Toxic (P Listed) |
| octolite | DOT Explosive | |
| octonal | DOT Explosive | |
| oestradiol-17 beta | IARC List of Known and Suspected Human Carcinogens | |
| oestrone | 53-16-7 | IARC List of Known and Suspected Human Carcinogens |
| oil or orange SS | 2646-17-5 | IARC List of Known and Suspected Human Carcinogens |
| Osmium oxide OsO4, (T-4)- | 20816-12-0 | EPA Acutely Toxic (P Listed) |
| Osmium tetroxide | 20816-12-0 | EPA Acutely Toxic (P Listed) |
| Oxamyl | 23135-22-0 | EPA Acutely Toxic (P Listed) |
| oxydianiline, 4,4'- | 101-80-4 | IARC List of Known and Suspected Human Carcinogens |
| oxymentholone | IARC List of Known and Suspected Human Carcinogens | |
| Ozone | 10028-15-6 | Acutely Toxic |
| panfuran S [dihydroxymethylfuratizine] | 794-93-4 | IARC List of Known and Suspected Human Carcinogens |
| Parathion | 56-38-2 | EPA Acutely Toxic (P Listed) |
| p-Chloroaniline | 106-47-8 | EPA Acutely Toxic (P Listed) |
| p-Diazidobenzene | DOT Forbidden | |
| Peracetic acid | 79-21-0 | 49 C.F.R. § 173.225 |
| Peroxyacetic acid | 79-21-0 | 49 C.F.R. § 173.225 |
| petasitenine | 60102-37-6 | IARC List of Known and Suspected Human Carcinogens |
| phenacetin | 62-44-2 | IARC List of Known and Suspected Human Carcinogens |
| phenazopyridine | 94-78-0 | IARC List of Known and Suspected Human Carcinogens |
| phenazopyridine hydrochloride | 136-40-3 | IARC List of Known and Suspected Human Carcinogens |
| phenelzine | 51-71-8 | IARC List of Known and Suspected Human Carcinogens |
| phenobarbital | 50-06-6 | IARC List of Known and Suspected Human Carcinogens |
| Phenol, (3,5-dimethyl-4-(methylthio)-, methylcarbamate | 2032-65-7 | EPA Acutely Toxic (P Listed) |
| Phenol, 2-(1-methylpropyl)-4,6-dinitro- | 88-85-7 | EPA Acutely Toxic (P Listed) |
| Phenol, 2,4,6-trinitro-, ammonium salt (R) | 131-74-8 | EPA Acutely Toxic (P Listed) |
| Phenol, 2,4-dinitro- | 51-28-5 | EPA Acutely Toxic (P Listed) |
| Phenol, 2-cyclohexyl-4,6-dinitro- | 131-89-5 | EPA Acutely Toxic (P Listed) |
| Phenol, 2-methyl-4,6-dinitro-, & salts | 534-52-1 | EPA Acutely Toxic (P Listed) |
| Phenol, 3-(1-methylethyl)-, methyl carbamate | 64-00-6 | EPA Acutely Toxic (P Listed) |
| Phenol, 3-methyl-5-(1-methylethyl)-, methyl carbamate | 2631-37-0 | EPA Acutely Toxic (P Listed) |
| Phenol, 4-(dimethylamino)-3,5-dimethyl-, methylcarbamate (ester) | 315-18-4 | EPA Acutely Toxic (P Listed) |
| phenoxybenzamine and its hydrochloride | 59-96-1 | IARC List of Known and Suspected Human Carcinogens |
| phenyl-beta-naphthylamine, n- | 135-88-6 | IARC List of Known and Suspected Human Carcinogens |
| Phenylmercury acetate | 62-38-4 | EPA Acutely Toxic (P Listed) |
| phenylphenol, o- | 90-43-7 | IARC List of Known and Suspected Human Carcinogens |
| Phenylthiourea | 103-85-5 | EPA Acutely Toxic (P Listed) |
| phenytoin (and its sodium salts) | 57-41-0 | IARC List of Known and Suspected Human Carcinogens |
| Phorate | 298-02-2 | EPA Acutely Toxic (P Listed) |
| Phosgene | 75-44-5 | EPA Acutely Toxic (P Listed) |
| Phosphine | 7803-51-2 | EPA Acutely Toxic (P Listed) |
| Phosphoric acid, diethyl 4-nitrophenyl ester | 311-45-5 | EPA Acutely Toxic (P Listed) |
| Phosphorodithioic acid, O,O-diethyl | 298-04-4 | EPA Acutely Toxic (P Listed) |
| Phosphorodithioic acid, O,O-dimethyl S-[2-(methylamino)-2-oxoethyl] ester | 60-51-5 | EPA Acutely Toxic (P Listed) |
| Phosphorofluoridic acid, bis(1-methylethyl) ester | 55-91-4 | EPA Acutely Toxic (P Listed) |
| Physostigmine salicylate | 57-64-7 | EPA Acutely Toxic (P Listed) |
| Physostigmine | 57-47-6 | EPA Acutely Toxic (P Listed) |
| Pinanyl hydroperoxide | 28324-52-9 | 49 C.F.R. § 173.225 |
| Plumbane, tetraethyl- | 78-00-2 | EPA Acutely Toxic (P Listed) |
| p-Menthyl hydroperoxide | 26762-92-5 | 49 C.F.R. § 173.225 |
| p-Nitroaniline | 100-01-6 | EPA Acutely Toxic (P Listed) |
| polybrominated biphenyls [PBBs] | 67774-32-7 | IARC List of Known and Suspected Human Carcinogens |
| polychlorinated biphenyls [PCBs] | 53469-21-9 | IARC List of Known and Suspected Human Carcinogens |
| ponceau 3R | 3564-09-8 | IARC List of Known and Suspected Human Carcinogens |
| ponceau MX | 3761-53-3 | IARC List of Known and Suspected Human Carcinogens |
| Potassium | 7440-09-7 | Peroxidizable |
| Potassium cyanide | 151-50-8 | EPA Acutely Toxic (P Listed) |
| Potassium silver cyanide | 506-61-6 | EPA Acutely Toxic (P Listed) |
| procarbazine | 671-16-9 | IARC List of Known and Suspected Human Carcinogens |
| procarbazine hydrochloride trade name=matulan | 366-70-1 | IARC List of Known and Suspected Human Carcinogens |
| Promecarb | 2631-37-0 | EPA Acutely Toxic (P Listed) |
| Propanal, 2-methyl-2-(methyl-sulfonyl)-, O-[(methylamino)carbonyl] oxime | 1646-88-4 | EPA Acutely Toxic (P Listed) |
| Propanal, 2-methyl-2-(methylthio)- | 116-06-3 | EPA Acutely Toxic (P Listed) |
| propane sultone, 1,3- | 1120-71-4 | IARC List of Known and Suspected Human Carcinogens |
| Propanenitrile | 107-12-0 | EPA Acutely Toxic (P Listed) |
| Propanenitrile, 2-hydroxy-2-methyl- | 75-86-5 | EPA Acutely Toxic (P Listed) |
| Propanenitrile, 3-chloro- | 542-76-7 | EPA Acutely Toxic (P Listed) |
| Propargyl alcohol | 107-19-7 | EPA Acutely Toxic (P Listed) |
| propiolactone, beta- | 57-57-8 | IARC List of Known and Suspected Human Carcinogens |
| propylene dichloride [1,2-dichloropropane] | 78-87-5 | IARC List of Known and Suspected Human Carcinogens |
| propylene oxide | 75-56-9 | IARC List of Known and Suspected Human Carcinogens |
| propyleneimine [1,2-propylenimine or 2-methylaziridine] | 75-55-8 | IARC List of Known and Suspected Human Carcinogens |
| propylthiouracil | 51-52-5 | IARC List of Known and Suspected Human Carcinogens |
| Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-, & salts | 54-11-5 | EPA Acutely Toxic (P Listed) |
| quercetin | 117-39-5 | IARC List of Known and Suspected Human Carcinogens |
| Radioactive Materials (Non-Excempt) | OSHA Listed Chemicals | |
| reserpine | 50-55-5 | IARC List of Known and Suspected Human Carcinogens |
| S-[(ethylthio)methyl] ester | EPA Acutely Toxic (P Listed) | |
| S-[2-(ethylthio)ethyl] ester | EPA Acutely Toxic (P Listed) | |
| safrole | 94-59-7 | IARC List of Known and Suspected Human Carcinogens |
| Selenious acid, dithallium(1+) salt | 12039-52-0 | EPA Acutely Toxic (P Listed) |
| selenium sulfide | 7488-56-4 | IARC List of Known and Suspected Human Carcinogens |
| Selenourea | 630-10-4 | EPA Acutely Toxic (P Listed) |
| senkirkine | 2318-18-5 | IARC List of Known and Suspected Human Carcinogens |
| Silver cyanide | 506-64-9 | EPA Acutely Toxic (P Listed) |
| Sodium 2-diazo-1-naphthol-4-sulphonate | 49 C.F.R. § 173.224 | |
| Sodium 2-diazo-1-naphthol-5-sulphonate | 2657-00-3 | 49 C.F.R. § 173.224 |
| Sodium Amide | 7782-92-5 | Peroxidizable |
| Sodium azide | 26628-22-8 | EPA Acutely Toxic (P Listed) |
| Sodium cyanide | 143-33-9 | EPA Acutely Toxic (P Listed) |
| Sodium metal | 7440-23-5 | Water Reactive |
| sodium o-phenylphenate | 132-27-4 | IARC List of Known and Suspected Human Carcinogens |
| spironolactone | 52-01-7 | IARC List of Known and Suspected Human Carcinogens |
| sterigmatocystin | 10048-13-2 | IARC List of Known and Suspected Human Carcinogens |
| streptozotocin | 18883-66-4 | IARC List of Known and Suspected Human Carcinogens |
| Strychnidin-10-one, & salts | 57-24-9 | EPA Acutely Toxic (P Listed) |
| Strychnidin-10-one, 2,3-dimethoxy- | 35757-3 | EPA Acutely Toxic (P Listed) |
| Strychnine, & salts | 57-24-9 | EPA Acutely Toxic (P Listed) |
| Styrene | 100-42-5 | Peroxidizable |
| styrene oxide | 96-09-3 | IARC List of Known and Suspected Human Carcinogens |
| sulfallate | 95-06-7 | IARC List of Known and Suspected Human Carcinogens |
| sulfamethoxazole | 723-46-6 | IARC List of Known and Suspected Human Carcinogens |
| Sulfuric acid, dithallium(1+) salt | 7446-18-6 | EPA Acutely Toxic (P Listed) |
| symphytine | 22571-95-5 | IARC List of Known and Suspected Human Carcinogens |
| telone II (mostly 1,3-dichloropropene) | 542-75-6 | IARC List of Known and Suspected Human Carcinogens |
| tert-Amyl hydroperoxide | 3425-61-4 | 49 C.F.R. § 173.225 |
| tert-Amyl peroxy-2-ethylhexanoate | 686-31-7 | 49 C.F.R. § 173.225 |
| tert-Amyl peroxy-2-ethylhexyl carbonate | 70833-40-8 | 49 C.F.R. § 173.225 |
| tert-Amyl peroxybenzoate | 4511-39-1 | 49 C.F.R. § 173.225 |
| tert-Amyl peroxyneodecanoate | 68299-16-1 | 49 C.F.R. § 173.225 |
| tert-Amyl peroxypivalate | 29240-17-3 | 49 C.F.R. § 173.225 |
| tert-Amylperoxy-3,5,5-trimethylhexanoate | 49 C.F.R. § 173.225 | |
| tert-Butoxycarbonyl azide | DOT Forbidden | |
| tert-Butyl cumyl peroxide | 30580-75-7 | 49 C.F.R. § 173.225 |
| tert-Butyl hydroperoxide | 75-91-2 | 49 C.F.R. § 173.225 |
| tert-Butyl monoperoxymaleate | 1931-62-0 | 49 C.F.R. § 173.225 |
| tert-Butyl monoperoxyphthalate | 15042-77-0 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxy-2-ethylhexanoate | 3006-82-4 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxy-2-ethylhexylcarbonate | 49 C.F.R. § 173.225 | |
| tert-Butyl peroxy-2-methylbenzoate | 22313-62-8 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxy-3,5,5-trimethylhexanoate | 13122-18-4 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxyacetate | 107-71-1 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxyacetate | DOT Forbidden | |
| tert-Butyl peroxybenzoate | 614-45-9 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxybutyl fumarate | 49 C.F.R. § 173.225 | |
| tert-Butyl peroxycrotonate | 23474-91-1 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxydiethylacetate | 2550-33-6 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxyisobutyrate | 109-13-7 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxyneodecanoate | 26748-41-4 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxyneoheptanoate | 26748-38-9 | 49 C.F.R. § 173.225 |
| tert-Butyl peroxypivalate | 927-07-2 | 49 C.F.R. § 173.225 |
| tert-Butylperoxy isopropylcarbonate | 2372-21-6 | 49 C.F.R. § 173.225 |
| tert-Butylperoxystearylcarbonate | 49 C.F.R. § 173.225 | |
| tert-Hexyl peroxypivalate | 51938-28-4 | 49 C.F.R. § 173.225 |
| tert-Hexylperoxyneodecanoate | 49 C.F.R. § 173.225 | |
| testosterone and its esters | 58-22-0 | IARC List of Known and Suspected Human Carcinogens |
| tetrachlorodibenzo-dioxin [TCDD] | IARC List of Known and Suspected Human Carcinogens | |
| tetrachlorodibenzo-p-dioxin, 2,3,7,8- [TCDD] | 1746-01-6 | IARC List of Known and Suspected Human Carcinogens |
| tetrachloroethylene [perchloroethylene] | 127-18-4 | IARC List of Known and Suspected Human Carcinogens |
| tetrachlorvinphos | 22248-79-9 | IARC List of Known and Suspected Human Carcinogens |
| Tetraethyl lead | 78-00-2 | EPA Acutely Toxic (P Listed) |
| Tetraethyl pyrophosphate | 107-49-3 | EPA Acutely Toxic (P Listed) |
| Tetraethyldithiopyrophosphate | 3689-24-5 | EPA Acutely Toxic (P Listed) |
| Tetrafluoroethylene | 116-14-3 | Peroxidizable |
| Tetrahydrofuran | 109-99-9 | Peroxidizable |
| Tetralin | 119-64-2 | Peroxidizable |
| Tetramine palladium (II) nitrate | 49 C.F.R. § 173.224 | |
| Tetranitromethane (R) | 509-14-8 | EPA Acutely Toxic (P Listed) |
| Tetraphosphoric acid, hexaethyl ester | 757-58-4 | EPA Acutely Toxic (P Listed) |
| Thallic oxide | 1314-32-5 | EPA Acutely Toxic (P Listed) |
| Thallium oxide Tl2 O3 | 1314-32-5 | EPA Acutely Toxic (P Listed) |
| Thallium(I) selenite | 12039-52-0 | EPA Acutely Toxic (P Listed) |
| Thallium(I) sulfate | 7446-18-6 | EPA Acutely Toxic (P Listed) |
| thioacetamide | 62-55-5 | IARC List of Known and Suspected Human Carcinogens |
| thiodianiline, 4,4'- | 139-65-1 | IARC List of Known and Suspected Human Carcinogens |
| thiotepa | 52-24-4 | IARC List of Known and Suspected Human Carcinogens |
| thiourea | 62-56-6 | IARC List of Known and Suspected Human Carcinogens |
| Thorium Dioxide | Select Carcinogen | |
| tolidine, o- | 119-93-7 | IARC List of Known and Suspected Human Carcinogens |
| Toluene | 108-88-3 | Reproductive Toxin |
| toluene diisocyanate [TDI] | 584-84-9 | IARC List of Known and Suspected Human Carcinogens |
| toluidine hydrochloride, o- | 540-23-8 | IARC List of Known and Suspected Human Carcinogens |
| toluidine, o- | 95-53-4 | IARC List of Known and Suspected Human Carcinogens |
| toluidine, p- | 106-49-0 | IARC List of Known and Suspected Human Carcinogens |
| toxaphene | 8001-35-2 | IARC List of Known and Suspected Human Carcinogens |
| Treosulfan | 299-75-2 | Select Carcinogen |
| triafur [2-amino-5-(nitro-2-furyl)-1,3,4-thiadiazole] | IARC List of Known and Suspected Human Carcinogens | |
| trichloroethane, 1,1,2- | 79-00-5 | IARC List of Known and Suspected Human Carcinogens |
| trichloroethylene | 79-01-6 | IARC List of Known and Suspected Human Carcinogens |
| trichlorophenol, 2,4,6- | 88-06-2 | IARC List of Known and Suspected Human Carcinogens |
| trichloropropane, 1,2,3- | 96-18-4 | IARC List of Known and Suspected Human Carcinogens |
| tris(1-aziridinyl)phosphine sulfide trade name=thiotepa | 52-24-4 | IARC List of Known and Suspected Human Carcinogens |
| tris(2,3-dibromopropyl)phosphate | 126-72-7 | IARC List of Known and Suspected Human Carcinogens |
| tris(aziridinyl)-p-benzoquione [triaziquone] | 68-76-8 | IARC List of Known and Suspected Human Carcinogens |
| trp-P-1 [3-amino,1,4-dimethyl-5H-pyrido[4,3-b]indole] | 62450-06-0 | IARC List of Known and Suspected Human Carcinogens |
| trp-P-2 [3-amino-1-methyl-5H-pyrido[4,3-b]indole] | IARC List of Known and Suspected Human Carcinogens | |
| trypan blue | 72-57-1 | IARC List of Known and Suspected Human Carcinogens |
| uracil mustard trade name=uramustine | 66-75-1 | IARC List of Known and Suspected Human Carcinogens |
| urethane [ethyl carbamate] | 51-79-6 | IARC List of Known and Suspected Human Carcinogens |
| Vinyl Actetate | 108-05-4 | Peroxidizable |
| Vinyl bromide | 593-60-2 | IARC List of Known and Suspected Human Carcinogens |
| Vinyl Chloride | 75-01-4 | Peroxidizable, Reproductive Toxin, Select Carcinogen |
| vinyl fluoride | 75-02-5 | IARC List of Known and Suspected Human Carcinogens |
| Vinylacetylene | 689-97-4 | Peroxidizable |
| vinylcyclohexene, 4- | 100-40-3 | IARC List of Known and Suspected Human Carcinogens |
| vinylidene chloride [1,1-dichloroethylene] | 75-35-4 | IARC List of Known and Suspected Human Carcinogens |
| vinylidene fluoride monomer | 75-38-7 | IARC List of Known and Suspected Human Carcinogens |
| Vinylidine Chloride | 75-35-4 | Peroxidizable |
| Vinylpyridine | 1337-81-1 | Peroxidizable |
| Xylene | 1330-20-7 | Reproductive Toxin |
| zearalenone | 17924-92-4 | IARC List of Known and Suspected Human Carcinogens |
| zinc chromate | 13530-65-9 | IARC List of Known and Suspected Human Carcinogens |